rfhg_194630.1

Basic information about the TSS

---

TSS ID: rfhg_194630.1 Species: human Chr: chr17		Start: 45035023 End: 45035023 Strand: -
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC018132:21 GeneID: 79877 HGNC/MGI_ID: HGNC:26238 UniProt_ID: Nearer transcript ids and distances: ENST00000452796.6:-118 BC033299:-118 LF209382:-131 MA444959:-131 ENST00000592902.5:134 JF432622:138 KJ894749:138 KJ905540:138 LF328107:197 MA563684:197 view more...

Gene_name: dephospho-CoA kinase domain containing Gene_symbol: DCAKD Gene_synonyms: FLJ22955 Gene_source: HGNC:26238

TATA-Box annotation

---

Distance to TSS:	16609
Nearest PromoterID:	NM_001128631
Entrez ID:	79877
Nearest Unigene:	Hs.463148
Nearest Refseq:	NM_024819
Nearest Ensembl:	ENSG00000172992
Gene Name:	dephospho-CoA kinase domain containing
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DCAKD p2@DCAKD p3@DCAKD p4@DCAKD p5@DCAKD p6@DCAKD p7@DCAKD p8@DCAKD p9@DCAKD p10@DCAKD
Sample		p1@DCAKD	p2@DCAKD	p3@DCAKD	p4@DCAKD	p5@DCAKD	p6@DCAKD	p7@DCAKD	p8@DCAKD	p9@DCAKD	p10@DCAKD
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	16.36	3.51	4.09	6.82	0.19	0.19	0.97	0.97	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	20.03	5.46	4.25	5.87	0.61	0.40	0.61	0.61	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.20	4.82	1.74	4.05	0.39	0.00	0.77	0.39	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.84	3.12	2.70	4.16	0.00	0.21	0.42	0.62	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	4.05	4.72	4.27	0.22	0.45	1.57	0.67	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.83	4.46	2.71	3.49	0.00	0.19	0.78	0.58	0.39	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.43	5.88	3.70	7.19	0.22	0.00	0.87	0.44	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.26	5.57	2.66	5.09	0.73	0.24	0.73	0.48	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.95	3.85	3.42	3.63	0.85	0.21	1.07	1.50	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.97	4.64	1.16	6.96	0.00	0.00	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.21	5.66	2.02	5.66	0.40	0.00	0.40	0.40	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.11	5.29	1.63	6.10	0.00	0.41	0.00	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11.44	5.32	9.19	1.93	0.97	0.48	6.13	1.77	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.63	5.56	7.22	2.10	0.45	0.75	4.06	1.05	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.66	5.71	7.03	1.10	0.22	0.88	5.71	2.42	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.57	4.78	5.28	3.02	0.00	0.25	4.28	1.26	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.70	3.71	4.59	0.87	0.00	0.22	2.84	1.31	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.92	2.11	8.01	2.11	0.42	0.84	5.91	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	2.13	5.33	1.60	1.07	0.00	4.27	1.60	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.82	5.12	6.62	0.75	0.15	0.45	4.36	0.90	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.49	4.81	5.88	1.34	0.27	0.00	4.01	0.94	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	5.01	5.35	2.59	0.52	0.35	4.14	1.21	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	4.65	4.52	1.16	1.03	1.03	4.27	1.03	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.98	3.40	2.43	1.46	1.21	0.24	3.40	0.73	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.80	4.64	5.93	2.06	0.26	0.77	6.19	0.77	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	2.85	6.01	1.27	0.32	0.63	4.11	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	3.30	8.79	1.65	0.55	1.10	2.75	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	7.31	4.95	2.83	0.24	1.41	5.66	1.65	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.91	4.85	5.81	1.94	0.48	0.81	1.94	1.29	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.05	4.52	4.89	1.27	0.54	0.72	4.16	0.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.12	3.77	4.19	0.21	0.00	0.84	2.72	1.26	1.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.99	5.67	4.69	1.37	0.59	0.59	1.76	0.98	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.23	4.85	5.06	1.27	0.42	0.21	3.17	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.27	5.77	4.95	1.81	0.00	0.66	2.97	1.32	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.36	3.74	4.86	2.62	0.37	1.12	4.49	0.93	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.90	5.17	5.37	1.53	0.57	0.19	2.11	1.34	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.38	5.52	5.11	0.82	0.00	0.20	3.27	1.23	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.87	3.22	3.43	1.01	0.20	0.40	3.83	0.81	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.29	5.67	2.97	0.81	0.81	0.81	1.89	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.44	3.12	6.96	2.16	0.48	1.20	3.60	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.00	3.76	4.71	1.18	0.24	0.47	4.71	0.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.42	4.83	5.56	1.17	0.00	0.88	3.37	0.59	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.80	2.11	3.80	0.84	0.00	0.63	4.22	0.84	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.44	4.20	6.64	1.92	0.70	0.35	3.67	0.87	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.22	2.61	3.81	1.41	0.40	0.40	2.01	1.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	2.33	2.79	1.16	0.00	0.70	3.26	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.84	3.12	5.28	1.20	0.48	0.24	4.08	1.20	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	0.89	4.47	0.30	0.00	0.60	3.58	0.89	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.18	3.83	4.55	1.20	0.24	0.24	3.11	1.44	1.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.68	4.25	4.65	2.02	0.40	0.81	3.64	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.35	5.53	4.71	2.05	0.00	0.41	3.69	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.56	4.00	4.45	2.45	0.44	0.67	3.34	0.89	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.81	4.26	4.61	1.06	0.71	0.00	3.55	1.06	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	3.31	6.63	0.99	0.00	0.00	3.65	0.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2.52	1.68	3.36	0.84	0.00	0.00	1.68	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.97	5.05	5.97	3.21	0.00	1.38	0.92	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.32	4.21	7.45	1.94	0.00	0.97	4.21	0.97	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	6.10	6.42	1.28	0.32	0.00	2.57	1.28	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	6.92	8.17	7.23	0.94	0.31	0.63	2.20	0.31	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	4.94	7.05	2.12	0.71	0.00	1.41	2.12	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	3.36	3.36	1.12	0.56	0.00	3.36	1.68	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	6.37	6.37	1.59	0.00	0.80	3.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.17	3.06	5.10	1.02	0.00	0.00	3.06	1.70	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	3.57	5.52	1.30	0.00	0.32	2.60	1.30	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.23	3.55	3.90	1.42	0.35	0.35	2.13	1.42	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	1.95	6.34	0.98	0.00	0.49	4.39	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.89	2.98	1.49	0.00	0.99	0.00	2.98	1.98	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	3.28	2.35	0.47	0.47	0.00	3.75	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.64	4.64	4.97	0.33	0.00	0.00	4.31	1.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.19	3.71	3.40	0.93	0.62	0.31	6.81	1.55	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.42	4.59	3.97	1.83	0.31	0.00	4.89	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	6.34	3.17	4.43	0.79	0.16	0.00	4.75	0.16	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	7.86	4.01	3.53	1.28	0.80	0.00	3.69	1.12	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	5.73	4.33	2.93	1.02	0.25	0.13	2.93	0.38	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	4.48	4.48	1.49	0.00	0.75	0.75	3.74	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	5.36	3.68	1.67	0.67	0.33	0.67	2.34	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	5.74	4.47	0.00	1.91	0.00	0.00	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	2.20	1.10	0.00	0.00	0.00	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.48	2.26	4.97	2.26	0.45	0.45	1.35	0.90	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	19.46	10.43	6.60	2.26	0.70	0.87	7.82	1.39	2.95	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.62	3.91	8.02	2.54	0.20	0.78	3.72	0.78	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	6.18	3.09	2.32	0.77	0.26	0.26	1.29	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	3.35	1.67	3.90	1.39	0.28	0.00	1.39	0.00	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	10.58	1.76	5.88	0.59	0.00	0.00	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.13	4.02	5.71	2.41	0.56	0.24	4.83	1.93	0.56	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	6.46	2.26	2.90	0.97	0.65	0.32	1.94	0.32	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	3.73	3.20	0.00	0.53	0.00	3.20	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	3.90	1.67	5.56	1.11	1.11	0.56	4.45	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	5.82	2.08	1.25	0.00	1.25	5.82	0.83	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	7.53	2.76	3.27	0.00	0.75	0.00	2.51	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.85	5.24	3.60	0.00	0.00	0.65	3.93	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.09	3.04	1.83	1.52	0.61	0.00	2.44	0.61	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16.80	4.64	2.65	0.22	0.44	0.88	3.09	0.44	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	15.06	2.15	2.51	0.36	0.36	0.00	1.43	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	30.94	5.40	5.58	0.36	0.00	0.18	3.06	0.90	1.26	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	6.69	1.67	0.00	0.00	3.35	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.01	7.19	5.34	1.23	1.23	0.41	5.34	0.82	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	7.90	4.12	4.58	2.75	0.23	0.69	7.32	0.34	1.26	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.10	3.92	1.96	0.24	0.00	0.73	8.82	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	5.39	2.70	0.45	0.00	0.90	2.70	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.78	4.78	2.17	0.43	0.87	0.43	5.21	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00	0.00	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.28	3.89	0.90	0.00	0.30	0.00	4.78	0.30	1.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	1.26	0.00	0.00	1.26	3.79	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	4.62	1.98	0.00	0.00	0.00	1.32	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	4.87	1.62	0.65	0.00	0.32	4.22	0.97	1.95	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.77	4.85	1.94	0.49	0.00	0.97	3.88	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	3.56	1.19	0.00	0.00	0.00	3.56	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.78	6.03	1.13	0.00	0.00	0.00	2.26	1.13	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	6.53	1.45	0.73	0.00	0.73	2.90	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	6.27	0.00	0.00	1.25	0.00	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.08	5.11	3.29	0.66	0.16	0.16	3.79	0.33	1.15	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	6.82	0.00	0.00	0.00	0.00	2.73	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.77	2.87	0.60	0.15	0.00	0.45	1.66	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	7.50	2.14	0.54	0.54	0.54	2.14	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.67	4.72	0.94	0.00	0.19	0.00	2.83	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.35	5.35	1.87	0.53	0.27	0.00	3.47	0.53	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	1.95	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.47	4.64	1.82	0.00	0.50	0.00	3.81	0.83	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	2.40	2.40	0.00	0.00	0.00	2.40	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	10.62	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.23	5.66	2.40	0.17	0.17	0.17	4.12	0.69	1.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	12.58	4.19	0.00	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	5.83	2.43	0.49	0.49	0.00	4.85	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.11	5.69	2.28	0.00	0.00	0.76	3.79	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	6.06	0.00	1.21	0.00	0.00	6.06	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.99	3.42	2.85	0.00	0.00	0.00	1.14	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.77	4.49	1.50	0.43	0.43	0.00	4.49	0.43	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.94	2.32	2.58	0.52	0.00	0.00	5.94	0.26	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	6.57	1.41	0.00	0.00	0.00	4.69	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	5.14	1.93	0.32	0.00	0.00	3.54	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	2.85	0.71	0.71	0.00	0.71	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	1.75	1.75	0.00	0.58	0.00	2.34	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	3.31	3.01	0.30	0.60	0.00	4.52	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	3.56	3.56	0.00	0.00	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	6.61	1.53	0.51	0.00	1.02	5.09	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	6.37	2.04	0.00	0.51	0.25	4.33	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	3.81	1.27	0.64	0.00	0.00	3.18	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	6.90	2.59	0.00	0.43	0.00	3.88	0.43	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	6.77	1.27	0.21	0.00	0.21	2.54	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.06	2.61	1.16	0.29	0.00	0.00	2.90	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	7.56	1.89	0.00	0.00	0.00	3.78	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.27	5.59	1.70	0.34	0.34	0.34	2.88	0.68	0.85	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	2.32	2.32	0.00	0.00	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	6.34	0.00	0.00	2.11	0.00	8.45	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.43	4.72	0.86	0.64	0.21	0.00	2.79	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.22	1.80	0.60	0.60	0.00	0.00	4.21	0.00	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	5.10	2.92	0.00	0.00	0.73	4.37	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.98	3.68	2.76	0.92	0.46	0.69	3.91	0.46	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	2.55	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.86	3.81	1.78	0.00	0.76	0.25	4.32	0.00	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.75	5.78	1.03	0.21	0.00	0.00	3.92	1.03	1.03	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.81	6.12	1.53	0.61	0.31	0.00	3.06	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	4.78	1.43	0.00	0.00	0.48	2.87	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.87	4.88	2.22	0.44	0.00	0.00	2.22	0.44	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	4.58	4.58	0.00	0.00	0.00	1.53	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.22	3.88	2.77	0.00	0.55	0.55	2.77	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.30	6.36	2.91	0.26	0.00	0.79	4.24	0.53	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	4.72	1.09	0.36	0.00	0.00	2.54	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	54.41	9.09	9.58	3.07	2.58	1.60	6.63	1.84	4.54	0.00
Astrocyte - cerebellum, donor2	11580-120F5	35.09	5.65	9.24	2.05	0.51	1.03	3.25	2.40	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	32.72	6.08	9.65	1.68	0.63	1.05	9.86	1.05	1.47	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	51.59	8.71	9.06	2.44	2.09	0.70	7.32	1.05	3.49	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	32.03	6.47	6.31	3.88	0.81	0.97	3.40	0.65	0.81	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	74.58	6.86	7.61	4.03	2.98	0.30	4.33	1.64	1.19	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	50.69	11.81	8.95	2.64	0.80	0.92	8.14	1.26	1.95	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	52.37	7.77	9.90	3.13	1.00	0.88	7.39	1.88	1.88	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.68	10.58	8.65	3.98	0.80	0.23	5.92	1.14	2.05	0.00
Basophils, donor1	12241-129G9	1.57	6.02	0.26	0.00	0.00	0.00	1.05	0.00	0.26	0.00
Basophils, donor2	12242-129H1	2.89	4.33	0.72	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Basophils, donor3	12243-129H2	2.65	3.82	1.47	0.29	0.00	0.15	1.76	0.15	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	30.18	8.19	3.02	0.22	1.51	0.43	1.72	1.51	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	6.40	2.29	0.91	0.46	0.00	2.29	2.29	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	14.35	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	3.14	2.51	0.63	0.00	0.00	3.14	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.68	3.12	2.29	0.42	0.42	0.00	1.25	0.42	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	12.67	3.91	1.38	0.23	0.23	0.23	0.92	0.92	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	11.70	5.40	1.80	0.36	0.54	0.54	4.50	1.26	1.08	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.41	9.58	8.76	4.64	0.62	0.21	6.39	2.58	2.99	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.91	8.85	9.32	5.12	0.00	0.70	3.73	0.23	1.40	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.15	2.24	7.67	0.96	0.64	0.64	4.48	0.32	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	10.34	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.13	6.20	1.13	0.00	0.00	0.00	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1.11	6.50	1.11	0.19	0.00	0.00	1.11	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	2.85	5.05	1.98	0.00	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	2.55	4.53	4.81	0.00	0.00	0.28	1.98	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3.03	7.58	2.65	0.38	0.38	0.00	4.55	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2.30	6.25	4.27	0.33	0.00	0.00	1.97	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	1.30	4.48	0.43	0.00	0.00	0.00	0.43	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	1.21	2.72	0.60	0.00	0.00	0.00	0.30	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	1.66	4.03	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.84	1.34	0.17	0.00	0.00	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.28	2.48	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.50	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.78	2.35	0.78	0.00	0.00	0.00	0.39	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.07	1.60	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	2.18	0.00	0.00	0.00	0.00	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.70	2.58	0.47	0.00	0.00	0.00	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	2.64	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.19	3.12	0.15	0.00	0.00	0.00	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.60	1.80	0.60	0.20	0.00	0.00	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.04	2.08	0.00	0.00	0.21	0.00	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.92	1.14	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.45	1.36	0.45	0.00	0.00	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.34	2.15	0.54	0.27	0.00	0.00	0.27	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.52	3.14	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.84	2.52	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.73	2.20	0.00	0.00	0.00	0.00	0.18	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	1.06	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	3.14	0.87	0.00	0.00	0.00	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	4.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.29	3.45	0.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	1.64	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.46	3.01	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	2.55	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.09	3.49	0.87	0.00	0.00	0.00	0.65	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.31	3.23	0.92	0.00	0.23	0.00	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.87	4.55	0.87	0.22	0.00	0.00	0.65	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2.18	7.79	1.25	0.16	0.00	0.00	0.31	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	1.75	5.59	1.22	0.17	0.00	0.00	0.35	0.17	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.23	8.25	1.34	0.22	0.00	0.00	1.34	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.04	1.79	0.77	0.00	0.00	0.00	1.02	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.73	5.27	0.22	0.00	0.00	0.00	0.88	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	2.95	2.95	1.26	0.00	0.00	0.00	0.42	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	6.10	4.06	2.03	0.00	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	10.85	6.10	9.49	0.68	0.00	0.00	4.75	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4.14	6.21	2.07	0.00	1.04	0.00	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.80	5.33	4.26	0.00	0.00	0.00	4.80	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	6.97	7.50	2.68	0.00	0.00	0.00	3.75	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	9.13	5.62	1.40	0.00	0.00	0.00	2.81	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	2.35	7.06	0.00	0.00	0.78	3.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	9.23	2.64	6.59	0.00	1.32	0.00	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	3.29	3.29	1.64	0.00	0.82	0.00	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.08	4.35	1.45	0.00	0.00	0.00	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	6.06	4.54	2.52	0.00	0.00	0.00	1.51	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.53	13.33	0.40	0.00	0.00	0.40	2.83	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.59	5.99	0.40	0.00	0.00	0.00	0.80	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	2.01	2.01	4.02	0.00	0.00	0.00	4.02	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	3.93	2.25	2.81	0.56	0.00	0.00	3.37	1.12	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	12.02	4.13	10.52	0.38	0.00	1.88	7.52	1.50	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	6.54	3.83	9.70	1.58	0.00	0.68	3.61	1.58	2.25	0.00
CD4+ T Cells, donor1	11225-116C1	9.64	15.00	1.79	0.00	0.00	0.00	2.14	0.36	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	5.51	11.63	1.84	0.00	0.00	0.00	1.84	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	10.98	10.37	3.66	0.61	0.00	0.30	1.52	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7.66	14.80	5.36	0.51	0.00	0.00	3.83	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	10.11	14.37	5.17	0.45	0.22	0.00	2.25	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.02	10.06	4.60	0.57	0.29	0.00	5.17	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	10.43	18.49	3.32	0.95	0.47	0.00	4.27	1.90	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.96	21.07	4.21	0.70	0.00	0.00	1.40	2.11	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	26.37	3.30	0.00	0.00	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.19	9.10	3.18	0.72	0.00	0.14	3.32	0.29	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.59	13.39	4.74	0.00	0.00	0.17	2.54	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.00	9.51	5.00	0.48	0.00	0.00	3.06	0.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.93	11.66	2.24	0.45	0.00	0.00	4.03	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.99	13.28	4.54	0.00	0.35	0.00	2.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.24	19.80	3.52	0.00	0.00	0.00	3.08	0.88	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.32	15.60	2.11	1.26	0.00	0.00	3.79	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	8.73	13.92	5.61	1.66	0.00	0.42	2.70	0.62	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.68	12.03	3.01	0.00	0.00	0.33	3.34	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	15.23	19.31	2.45	0.27	0.27	0.00	5.98	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	25.19	20.90	5.36	1.07	0.00	0.00	2.14	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	32.28	1.79	0.00	0.00	0.00	8.97	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	13.54	7.23	0.93	0.19	0.00	3.15	0.56	0.93	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	7.80	16.03	6.28	1.95	0.22	0.22	1.95	1.52	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.25	11.35	5.25	0.42	0.00	0.42	2.73	0.42	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.56	16.68	2.02	0.00	0.00	0.00	3.03	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.96	12.56	1.30	0.00	0.00	0.43	1.73	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.46	16.56	5.23	0.00	0.00	0.00	2.18	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.35	10.39	3.46	0.00	0.00	0.00	2.97	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	7.39	12.92	2.77	0.00	0.00	0.00	6.46	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	11.17	8.37	4.19	0.00	0.00	0.00	2.79	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	10.52	17.45	5.82	0.28	0.28	0.00	3.88	0.83	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	15.21	20.61	5.89	0.00	0.49	0.25	5.15	1.47	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	21.56	3.08	0.00	0.00	0.00	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	12.53	11.46	5.37	0.36	0.00	0.00	3.94	1.79	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	11.08	2.77	0.00	0.00	0.00	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	5.89	7.20	1.64	0.00	0.33	0.00	2.95	0.65	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	4.51	10.14	1.13	0.38	0.00	0.00	4.51	0.75	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	7.83	10.60	3.03	0.25	0.00	0.00	3.03	0.76	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.33	4.36	2.06	1.61	1.38	0.46	2.75	0.23	1.38	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.29	5.99	3.83	1.92	0.96	0.00	3.59	0.72	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.44	5.20	4.10	2.19	0.55	0.27	6.02	0.00	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.62	4.20	3.90	0.90	0.30	0.30	4.50	1.50	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	29.28	4.80	5.04	1.44	1.44	0.00	4.56	0.72	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.69	2.73	3.64	1.82	1.14	0.68	5.46	0.68	1.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.51	4.13	3.48	1.30	0.65	0.65	3.48	1.09	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.69	3.68	6.05	1.32	0.79	0.53	2.90	0.79	2.11	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.34	3.99	3.99	1.64	0.23	0.47	3.28	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.70	4.83	3.62	2.42	0.00	0.30	1.81	1.21	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.56	3.20	3.78	1.16	1.45	0.29	3.78	0.87	1.45	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.25	3.73	3.46	2.66	0.53	0.00	3.20	0.80	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.01	3.50	0.44	2.19	0.00	0.44	5.25	0.00	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.75	2.73	2.73	2.28	0.00	0.46	3.64	1.37	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	2.98	1.49	1.49	0.00	0.75	2.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	35.30	2.16	3.60	0.36	1.44	1.44	6.48	0.72	1.80	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.64	5.75	4.32	0.00	0.29	0.29	4.03	1.44	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.46	5.42	4.71	1.41	2.12	0.94	3.77	0.94	2.59	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.52	5.07	5.70	1.90	0.95	0.32	4.75	0.95	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.91	2.77	4.31	2.77	0.31	0.00	3.69	2.15	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	20.20	5.13	2.56	1.28	0.32	0.00	3.53	0.64	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.77	2.68	2.29	1.91	0.38	0.38	5.74	1.91	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.82	1.97	3.55	1.97	1.18	0.79	2.76	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	1.51	0.76	2.27	0.00	0.00	4.54	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	4.01	1.61	2.41	0.00	0.80	4.82	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	19.58	4.90	3.50	2.10	2.80	0.00	5.60	0.00	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	22.04	11.02	4.01	1.00	2.00	0.00	5.01	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	9.14	1.83	0.00	0.00	0.00	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	2.96	1.98	0.49	0.49	0.00	4.45	1.98	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	6.84	4.74	3.26	1.47	0.21	0.74	3.79	0.84	0.63	0.00
Chondrocyte - de diff, donor1	11261-116G1	12.48	4.16	2.77	1.04	0.35	1.04	2.08	1.73	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.04	4.62	1.42	1.07	0.00	0.00	4.98	0.36	2.13	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.26	4.44	3.98	1.82	0.00	0.34	6.03	0.91	1.59	0.00
Chondrocyte - re diff, donor2	11339-117F7	2.69	1.79	0.90	2.69	0.00	0.00	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.68	2.02	6.07	0.40	0.00	0.00	4.45	2.43	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	22.38	6.31	9.07	2.07	0.46	0.46	4.82	0.69	1.26	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	19.24	4.92	2.57	0.43	1.07	0.43	2.14	0.86	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	22.74	4.42	4.78	1.86	1.06	0.88	4.87	1.24	0.44	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.61	11.00	7.52	2.02	1.19	0.46	11.65	0.83	1.19	2.66
Corneal Epithelial Cells, donor1	11526-119I5	34.25	10.32	3.73	1.10	1.32	0.00	8.34	2.20	2.42	0.00
Corneal Epithelial Cells, donor2	11606-120I4	17.06	6.83	5.69	0.00	0.00	0.00	3.41	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.53	6.65	2.05	1.02	0.26	0.00	4.86	2.05	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.81	6.77	2.15	0.17	0.00	0.33	3.63	0.50	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.58	5.99	1.26	0.00	0.00	0.00	2.84	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	13.80	0.00	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.70	4.64	2.27	0.22	0.00	0.11	2.16	0.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	8.20	3.07	5.12	0.34	0.00	1.02	2.39	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.92	1.96	4.57	1.31	0.00	0.65	3.26	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.19	4.36	3.39	0.48	0.00	0.48	2.90	3.39	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	5.00	4.34	0.33	0.00	0.83	1.17	0.33	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	1.76	2.93	0.59	0.59	0.59	0.59	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.66	5.09	2.83	1.41	0.00	0.28	1.70	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	3.15	1.18	0.00	0.00	0.79	0.39	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.65	2.62	4.65	0.58	0.58	0.58	2.33	0.29	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.23	5.18	4.24	1.65	0.00	0.94	2.82	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	8.41	3.68	3.68	1.05	0.00	0.00	1.58	0.88	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.10	1.55	2.44	0.00	0.00	0.89	1.99	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.61	3.96	3.96	0.00	0.00	0.30	2.13	1.22	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.58	6.20	5.07	0.28	0.00	0.85	1.97	0.85	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	5.05	2.08	0.00	0.00	0.59	3.27	0.00	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	2.60	2.60	0.00	0.00	0.52	1.04	0.52	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.07	5.10	2.27	0.00	0.14	0.71	2.84	0.85	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	10.00	6.40	6.40	0.00	0.00	0.80	2.00	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	5.24	2.10	0.00	0.00	0.00	2.62	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.28	6.71	5.72	0.75	0.12	1.12	3.23	0.25	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	11.73	4.13	1.96	0.43	0.22	0.43	1.52	1.09	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.53	3.05	3.05	0.49	0.49	0.12	1.95	0.24	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	18.20	2.28	7.96	2.28	0.00	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	2.10	4.19	0.70	0.00	0.00	3.49	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.32	2.20	1.73	0.47	0.31	0.47	1.41	0.63	0.00	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	26.63	6.60	1.95	0.73	0.73	0.24	4.15	0.98	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	10.40	0.00	0.00	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.57	2.87	2.05	0.41	0.00	0.41	5.34	1.23	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.60	5.47	1.53	0.77	0.11	0.55	1.97	0.77	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.10	3.36	1.95	0.76	0.11	0.22	2.38	0.22	0.54	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.58	4.37	2.55	0.85	0.61	0.61	2.67	0.36	0.73	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	7.78	14.88	4.50	1.77	0.00	0.82	3.55	0.27	0.82	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.54	5.59	1.58	0.42	0.11	0.32	4.85	0.63	1.16	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.01	8.17	5.53	1.84	0.00	0.26	1.05	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.63	3.32	2.99	2.33	0.33	0.00	1.99	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	7.71	4.99	3.63	1.36	0.00	0.45	0.91	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	3.79	2.27	0.00	0.00	0.00	5.31	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.62	6.31	3.47	0.79	0.47	0.63	1.58	0.79	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	7.27	3.94	6.37	2.73	0.61	0.30	5.76	0.00	1.52	0.00
Fibroblast - Cardiac, donor5	11456-119A7	8.38	4.70	3.43	0.76	0.25	0.00	2.03	0.63	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	3.94	1.82	3.34	0.76	0.00	0.00	2.58	0.30	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.18	4.42	8.44	2.95	0.67	0.40	6.16	2.81	1.47	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	1.29	2.59	0.43	0.86	0.43	4.31	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	5.86	2.93	0.00	0.00	1.46	8.79	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	27.91	6.23	6.00	2.31	0.46	1.85	5.30	1.38	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	16.62	7.63	9.33	3.39	0.68	1.19	8.99	1.19	3.22	0.00
Fibroblast - Dermal, donor1	11269-116G9	5.87	3.29	3.99	0.70	0.00	0.47	1.88	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.32	5.66	2.36	1.89	0.00	0.00	2.83	0.00	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.71	4.35	3.14	0.97	0.12	0.48	1.57	0.00	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	11.76	5.31	3.28	1.36	0.45	0.00	3.05	0.68	0.68	0.00
Fibroblast - Dermal, donor5	11454-119A5	7.68	5.58	3.31	1.05	0.17	0.35	2.09	0.35	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.04	6.01	6.50	1.95	0.00	0.81	3.09	0.49	0.49	0.00
Fibroblast - Gingival, donor1	11237-116D4	8.54	7.91	5.83	1.25	0.00	0.42	4.37	0.21	1.04	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.00	4.19	4.19	2.62	0.26	0.00	5.50	0.52	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	18.85	5.93	6.06	1.58	0.92	0.13	3.43	0.79	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	9.48	6.38	7.64	1.74	0.19	0.58	4.06	0.68	0.87	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	1.04	8.31	2.08	0.00	1.04	5.19	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.51	2.64	1.76	1.41	0.35	0.00	1.06	0.70	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	9.82	4.99	4.83	2.65	0.47	0.16	2.65	0.62	2.03	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.93	3.25	6.09	2.70	0.41	0.27	4.33	0.14	1.22	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.23	6.00	3.18	0.35	0.35	0.35	4.59	0.00	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	13.16	4.83	4.24	3.22	0.15	0.00	2.19	0.15	1.17	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.45	4.50	3.27	2.59	0.14	0.00	3.41	0.14	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.74	2.96	4.39	2.08	0.11	0.22	1.32	0.33	1.32	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.09	3.82	5.43	2.35	0.73	0.15	3.52	1.03	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	5.44	5.44	5.44	4.08	0.00	0.00	5.44	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	7.46	0.00	4.48	1.49	0.00	0.00	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	11.40	5.28	5.49	2.32	0.00	0.84	2.74	1.06	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	36.65	28.32	14.99	5.83	0.00	2.50	24.99	1.67	5.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	8.39	5.59	0.00	0.00	0.00	9.79	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.88	6.16	5.32	2.24	0.28	0.28	7.56	1.12	1.12	0.00
Fibroblast - Mammary, donor1	11540-120B1	36.13	15.02	14.21	2.84	0.81	0.81	7.31	2.84	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	23.97	7.99	3.99	3.99	0.00	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	17.87	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.52	5.63	6.40	1.55	1.16	0.39	2.91	0.39	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.48	6.83	8.19	3.79	0.61	0.30	3.64	0.91	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	15.61	12.24	8.87	0.92	0.00	0.61	3.06	0.92	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.45	5.72	1.91	1.91	0.38	0.00	4.58	1.53	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.83	2.70	2.43	1.35	0.27	0.27	4.05	0.54	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.39	2.44	3.02	1.28	0.12	0.00	2.55	0.46	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.51	5.53	3.65	0.66	0.11	0.99	0.99	0.11	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.93	14.02	5.69	1.83	0.61	0.41	5.08	1.02	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	2.67	7.35	2.67	0.00	1.34	3.34	0.67	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	3.95	6.72	1.98	0.00	0.40	3.56	0.00	2.77	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.53	7.14	6.35	2.58	0.60	0.20	2.78	0.60	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.59	5.15	4.44	1.42	0.18	0.18	8.17	0.89	3.37	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.43	6.31	2.56	1.18	0.59	0.79	3.94	0.00	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.03	6.92	6.02	1.50	0.30	0.00	3.31	0.90	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.07	6.15	4.86	1.08	0.32	0.43	7.23	0.97	0.65	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.85	6.58	8.86	0.76	0.76	0.25	4.56	0.76	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.52	4.10	3.94	0.66	0.33	0.49	4.43	0.66	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	8.42	5.01	6.42	0.20	0.20	0.60	3.61	0.40	1.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	7.13	5.32	2.01	0.70	0.30	0.30	4.72	1.00	0.80	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.69	10.58	3.93	1.81	0.30	0.30	2.42	0.30	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.43	4.06	4.47	1.16	0.33	0.08	2.90	0.41	1.49	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.55	6.67	6.84	3.42	0.00	0.51	9.06	1.03	3.42	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.87	6.57	6.57	0.66	0.33	0.00	3.61	0.66	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.73	5.43	3.73	0.85	0.32	0.75	4.05	0.75	0.85	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	11.30	4.22	4.05	0.84	0.17	0.17	4.72	0.84	1.18	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.61	5.49	1.73	0.78	0.31	0.47	2.20	0.47	0.63	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	10.46	3.49	3.49	0.00	1.74	0.00	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6.93	4.68	1.56	0.00	0.35	0.00	0.87	0.17	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.81	7.29	2.34	0.78	0.00	0.00	1.30	1.04	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.75	3.83	1.79	0.26	0.51	0.51	0.51	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	0.77	1.53	2.30	0.00	0.00	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	1.91	1.28	0.00	0.64	0.00	1.28	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	22.82	1.14	9.13	2.28	0.86	0.00	0.86	1.14	0.86	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	27.30	1.38	6.89	1.38	3.86	0.00	6.34	1.93	1.10	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.05	2.05	6.16	0.68	3.88	0.91	3.65	1.37	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.18	2.58	6.34	1.19	0.99	0.00	1.39	1.19	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	23.26	1.32	5.29	0.79	2.38	0.00	4.76	1.32	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.29	2.28	4.89	0.98	1.96	0.00	2.94	2.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.44	3.54	2.21	2.21	1.33	0.00	0.88	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	31.80	1.70	6.22	1.41	1.27	0.42	2.40	1.98	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.74	2.34	7.76	0.49	2.22	0.25	2.46	2.71	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	28.74	1.88	8.33	1.34	1.88	0.00	1.88	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.64	2.35	9.42	0.74	1.12	0.37	2.11	1.61	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.95	1.52	5.40	0.69	1.38	0.00	0.97	0.69	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.50	0.81	1.83	1.22	0.61	0.20	1.42	0.20	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.11	3.19	6.62	1.83	1.14	0.23	5.02	1.14	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	29.15	2.37	5.36	0.25	1.87	0.25	3.86	1.25	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.51	1.53	3.93	0.00	1.09	0.00	1.53	1.09	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	29.55	4.43	7.68	1.77	0.59	0.59	5.02	2.36	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.00	2.86	9.22	1.27	1.43	0.32	4.29	0.95	1.91	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.96	1.34	7.37	2.23	1.34	0.22	2.46	1.34	1.56	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.25	2.82	7.46	2.22	1.21	0.81	5.85	2.02	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	32.74	2.88	8.82	1.19	0.85	0.17	2.54	1.02	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	43.45	4.26	8.16	1.77	2.04	0.71	2.75	1.06	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.34	5.10	17.07	3.95	2.81	0.83	10.30	3.23	3.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.09	4.95	15.88	2.56	0.85	0.85	9.22	3.93	4.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.57	3.76	9.52	1.44	0.55	0.44	3.98	2.88	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.20	2.91	9.15	1.83	1.00	0.50	3.83	1.66	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.63	3.68	7.15	2.65	1.43	0.20	4.29	1.02	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	2.27	10.73	2.06	0.83	0.62	5.36	3.92	1.24	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.25	3.11	10.72	1.27	0.92	0.58	4.73	3.46	1.50	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.01	3.50	8.84	0.67	0.67	0.50	3.34	1.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.88	3.31	12.12	1.32	2.20	1.54	5.51	2.42	1.76	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	25.83	3.57	12.05	1.72	1.35	0.86	7.26	2.71	2.34	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.72	3.08	11.18	1.95	1.46	0.32	5.35	2.11	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.47	6.09	10.58	2.57	2.25	0.32	7.38	2.89	2.57	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.66	3.03	7.86	1.04	0.85	0.47	2.37	1.71	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	22.14	3.32	7.91	2.53	0.95	0.00	3.95	0.79	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	25.54	6.08	8.51	1.22	0.00	0.61	2.43	3.04	1.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.73	3.35	8.78	0.94	0.73	0.10	3.55	1.57	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.96	3.95	6.37	1.98	0.66	0.22	4.17	2.20	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.37	4.21	9.26	1.40	0.56	0.84	5.33	1.96	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.33	3.15	5.46	0.56	0.56	0.28	1.76	0.46	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.06	2.14	5.62	1.07	0.27	0.00	2.94	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.96	1.53	6.12	1.22	0.46	0.46	1.22	0.92	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.06	2.07	6.74	0.65	0.78	0.13	1.68	1.68	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.41	4.34	7.86	0.54	1.08	0.00	4.07	3.52	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.09	3.32	9.03	0.92	0.92	0.55	4.42	1.47	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.37	5.26	7.24	0.66	1.10	0.22	3.73	2.19	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	38.68	18.84	15.87	4.96	1.98	0.00	9.92	3.97	6.94	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	21.24	3.69	5.67	0.92	1.45	0.53	3.69	0.79	1.19	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.75	2.82	7.06	0.81	0.40	0.40	2.62	1.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	96.83	32.79	37.11	4.57	5.59	2.29	37.11	11.69	15.50	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	32.05	1.99	6.17	0.80	1.79	0.40	0.60	1.39	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.35	1.54	7.24	1.69	1.23	0.31	1.54	1.85	0.77	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.28	1.64	11.05	2.66	1.43	0.20	2.05	0.61	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.22	1.25	2.82	1.56	0.31	0.00	2.19	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.58	1.13	4.52	1.41	0.28	0.00	1.70	0.57	1.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.52	0.46	5.07	1.84	0.00	0.46	1.84	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	0.00	2.47	0.00	0.00	0.00	7.42	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.92	1.16	5.80	1.55	1.55	0.39	1.93	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	1.60	6.42	1.60	1.60	0.00	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	3.48	10.43	1.74	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.74	1.30	4.88	1.63	0.65	0.00	2.60	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	1.65	6.59	2.06	0.82	0.00	2.47	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	3.33	6.66	0.00	0.00	0.00	0.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.05	2.24	2.52	1.40	0.56	0.00	1.96	1.68	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.86	3.60	6.21	0.98	1.31	0.33	2.94	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	17.62	2.52	7.55	5.03	2.52	0.00	1.68	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.76	2.23	6.68	3.50	0.64	0.64	4.77	0.95	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.72	1.36	5.77	1.70	1.02	0.00	4.08	2.72	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	0.00	8.35	2.09	0.00	0.00	4.18	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	17.75	1.15	9.16	2.29	1.72	0.00	9.74	1.15	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.75	1.78	7.99	0.89	1.48	0.30	5.33	2.96	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	5.08	5.08	1.69	1.69	0.00	1.69	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.85	2.49	7.04	3.31	0.83	0.41	7.04	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.22	2.99	5.06	1.84	0.92	0.23	2.99	1.84	2.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.45	1.92	2.69	1.54	1.92	0.00	5.38	1.92	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.86	2.93	4.89	0.65	0.98	0.33	5.54	0.33	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	1.34	2.01	1.34	2.01	0.00	2.01	1.34	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.67	3.08	6.55	2.70	1.54	0.39	8.48	3.47	2.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	20.54	2.74	7.19	3.42	0.68	0.00	7.87	2.40	2.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	0.00	2.48	2.48	4.97	0.00	14.91	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.20	0.94	13.21	0.94	1.89	0.47	8.02	2.36	2.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.92	0.60	8.45	3.02	1.21	0.00	8.45	3.02	3.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.42	3.56	8.14	3.05	2.03	0.00	9.16	4.07	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.92	1.20	8.77	2.39	1.60	0.00	4.39	3.59	3.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	26.64	1.48	5.43	1.48	0.49	0.49	6.91	1.97	2.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	4.72	9.44	2.36	2.36	0.00	8.26	5.90	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.67	1.75	13.42	1.75	0.58	0.00	11.67	1.75	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.89	1.32	6.14	1.32	1.76	0.44	9.22	6.14	3.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	9.32	2.54	7.63	0.85	1.70	0.00	9.32	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	17.31	2.39	5.97	0.60	0.60	0.00	4.78	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.87	1.94	5.82	1.46	0.49	0.00	3.88	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	5.71	5.71	1.14	1.14	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	1.25	3.74	0.83	0.00	0.00	4.16	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	5.62	2.25	2.25	0.00	0.00	6.75	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.29	12.05	4.44	1.90	0.00	0.32	8.88	0.32	2.22	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	12.11	4.60	0.84	0.00	0.00	9.61	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.75	5.11	1.51	0.58	0.35	0.00	2.20	0.35	0.58	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.83	4.39	2.53	0.68	0.17	0.17	1.69	0.34	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.87	4.10	1.37	0.68	0.46	0.46	0.68	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.73	4.59	1.97	0.66	0.66	0.11	1.75	0.22	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.18	4.30	1.93	0.86	0.21	0.21	1.72	1.07	0.64	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.83	3.23	1.29	1.29	0.43	0.43	1.51	1.08	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.84	3.99	3.61	1.12	0.12	0.37	1.99	0.12	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.44	5.15	2.40	0.86	0.34	0.34	1.54	0.51	0.69	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	3.84	0.64	0.96	0.32	0.00	0.64	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	6.72	3.92	0.56	0.00	1.12	3.92	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.91	9.09	3.90	1.73	0.43	0.43	3.90	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	7.93	7.93	0.00	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.10	9.88	7.76	1.06	0.35	1.76	3.88	0.35	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	22.52	3.63	5.81	1.45	0.73	0.00	5.09	1.45	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.01	4.55	2.62	0.87	0.87	0.52	1.57	0.35	0.17	0.00
Hepatocyte, donor1	11523-119I2	7.26	8.47	2.42	0.00	0.00	0.00	6.05	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	3.23	3.23	6.46	5.39	0.00	0.00	0.00	0.00	0.00	2.15
Hepatocyte, donor3	11684-122I1	6.14	7.98	6.14	1.23	0.00	0.00	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.89	10.44	7.83	6.53	0.65	0.65	8.48	2.61	4.57	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	5.77	3.50	3.85	1.75	0.00	0.35	3.85	1.05	1.57	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.07	4.39	2.74	0.69	0.41	0.00	3.16	0.41	0.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	12.74	19.10	3.18	3.18	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	6.68	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	16.61	6.92	6.92	1.38	0.00	5.54	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	12.51	2.50	0.00	0.00	0.00	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	23.07	7.69	10.25	0.00	0.00	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	13.71	13.71	0.00	0.00	0.00	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	14.62	12.99	1.62	3.25	1.62	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	15.01	5.00	1.67	3.33	1.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	25.41	0.00	0.00	0.00	0.00	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	11.91	9.26	5.29	1.32	1.32	2.65	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	5.54	3.33	2.22	0.00	0.00	0.00	4.43	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	15.71	5.24	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	16.38	11.34	2.52	0.00	0.63	1.26	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	13.92	12.37	1.55	0.00	0.00	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	16.15	9.69	1.94	0.00	1.29	0.00	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	11.27	9.66	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.82	22.00	12.22	4.07	0.00	1.63	3.26	2.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.61	14.69	8.40	3.78	0.84	0.42	3.36	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	16.88	7.23	1.61	0.80	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	7.39	5.54	0.92	0.00	3.69	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	45.24	15.08	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	17.94	9.44	5.66	0.94	0.00	0.47	1.89	0.94	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	9.07	5.44	0.91	0.00	1.81	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	11.84	10.76	2.15	1.08	1.08	3.23	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	15.25	13.98	3.81	0.00	0.00	6.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.33	15.30	14.67	3.83	1.28	0.00	1.91	1.28	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	23.69	20.05	5.47	0.00	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.85	12.14	15.71	5.71	0.00	1.43	6.43	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	3.32	13.27	0.00	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.62	11.73	11.73	2.47	0.31	0.93	0.93	0.93	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	12.29	17.56	0.00	1.76	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	22.00	12.57	0.00	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	20.17	18.08	2.78	2.09	0.70	2.09	1.39	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	48.69	17.70	19.92	6.64	0.00	0.00	13.28	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	12.97	19.45	3.24	0.00	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	25.29	24.41	12.21	3.49	0.00	0.87	2.62	1.74	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	15.75	15.75	0.00	2.25	0.00	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	20.91	13.94	10.45	0.00	0.00	0.00	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	22.40	7.47	2.13	1.07	2.13	6.40	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	45.72	12.47	15.24	2.77	0.00	1.39	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	14.25	5.70	0.00	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	26.69	18.41	11.05	2.76	0.00	0.92	3.68	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	27.23	3.03	9.08	0.00	0.00	0.00	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	24.83	24.83	0.00	0.00	0.00	12.42	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	19.03	12.69	0.00	2.11	5.29	5.29	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.01	9.79	1.63	0.57	0.57	0.33	0.82	0.16	0.49	0.00
Keratinocyte - epidermal, donor2	11349-117G8	12.88	2.93	1.17	0.00	1.17	0.00	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	10.89	3.88	2.84	0.38	0.00	0.00	1.80	0.57	1.04	0.00
Keratinocyte - oral, donor1	11251-116E9	41.32	11.01	5.11	1.59	1.59	0.45	11.58	1.82	2.50	0.00
Keratocytes, donor1	11527-119I6	11.35	8.94	4.47	1.38	0.34	2.06	3.09	1.38	0.34	0.00
Keratocytes, donor2	11607-120I5	11.72	1.17	5.86	0.00	0.00	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	5.73	4.74	3.75	1.19	0.20	0.40	1.19	0.59	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	4.40	0.00	0.00	0.00	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	4.31	6.47	1.08	2.16	2.16	0.00	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.60	6.92	10.73	1.96	1.61	0.58	7.15	2.31	1.61	0.00
Lens Epithelial Cells, donor3	11690-122I7	15.74	4.24	4.74	1.11	0.30	0.00	3.03	0.61	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.35	8.18	3.20	0.71	0.12	0.47	4.62	0.24	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.98	4.19	1.12	0.56	0.00	0.00	1.95	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.50	7.40	2.99	0.16	0.31	0.16	1.26	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	4.30	1.08	0.00	0.00	0.00	1.61	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	3.15	1.26	0.00	0.00	0.00	0.63	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.93	5.61	2.26	0.65	0.00	0.11	1.73	0.97	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.10	6.98	2.05	0.00	0.00	0.82	2.46	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	2.28	2.28	0.00	0.00	0.25	2.53	0.00	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.04	5.07	1.83	0.70	0.00	0.14	1.69	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.35	1.98	0.79	0.79	0.00	0.00	1.19	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	3.88	1.55	0.00	0.58	0.58	1.94	0.19	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.44	5.37	3.15	0.37	0.00	0.00	2.22	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.57	5.92	2.09	0.00	0.00	1.05	1.39	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.35	6.44	2.39	0.24	0.72	0.72	2.15	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.32	4.94	2.20	0.00	0.27	0.55	1.51	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	3.39	4.62	3.39	0.62	0.00	0.31	1.85	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	4.68	3.12	0.00	0.31	1.25	0.94	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	5.67	4.39	0.18	0.37	0.18	2.56	0.00	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.95	5.59	2.63	0.33	0.33	0.00	1.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.84	3.22	1.46	1.17	0.00	0.59	0.88	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	4.48	1.99	0.50	0.25	0.50	2.49	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.36	5.82	2.91	0.00	0.00	0.00	1.45	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	4.58	2.15	0.54	0.00	0.27	2.42	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.30	4.09	2.88	0.30	0.00	0.30	3.03	0.15	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	3.11	1.04	0.00	0.00	1.04	3.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.42	4.82	1.88	0.21	0.21	0.63	2.30	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.47	5.56	3.76	0.15	0.00	0.00	1.20	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	3.44	1.38	0.00	0.00	0.00	4.13	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.59	5.46	1.32	0.75	0.19	0.94	1.88	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.15	5.73	2.01	0.85	0.21	0.53	2.23	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	1.94	3.88	4.36	0.00	0.00	0.48	1.94	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	5.29	2.32	0.33	0.00	0.66	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.19	5.08	3.22	0.74	0.00	0.12	1.86	0.62	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.66	6.29	2.22	0.74	0.00	0.00	2.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.67	3.46	2.22	0.25	0.00	0.25	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.46	5.22	1.24	0.41	0.00	0.00	2.34	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2.89	4.82	1.61	0.00	0.00	0.00	3.86	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.87	4.87	1.22	0.30	0.00	0.30	1.83	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.30	4.34	2.10	0.56	0.00	0.70	2.66	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	3.56	2.84	0.00	0.36	0.00	1.07	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	5.82	3.39	0.48	0.00	0.00	1.94	0.00	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.31	4.20	1.71	0.00	0.00	0.31	2.65	0.16	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	5.37	1.79	0.36	0.00	0.00	1.43	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	4.90	1.31	0.33	0.00	0.33	1.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	5.18	2.59	0.24	0.00	0.47	3.06	0.47	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4.70	7.43	3.84	0.50	0.00	0.25	1.98	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.15	2.56	1.54	0.51	0.00	0.51	0.26	0.26	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.58	4.18	3.28	0.30	0.00	0.30	1.79	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	9.06	0.00	0.00	0.00	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.81	6.90	0.77	1.53	0.77	0.77	4.60	3.07	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	7.42	0.74	0.74	0.74	2.23	1.48	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	11.42	1.27	0.42	0.42	0.00	9.31	0.85	2.96	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	24.62	13.36	2.81	0.00	0.00	0.00	7.03	2.81	2.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	7.47	1.87	0.00	0.00	0.93	5.60	0.93	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	9.79	11.34	1.03	0.00	1.03	0.00	9.27	2.06	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	7.14	1.19	0.00	4.76	0.00	3.57	2.38	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.02	9.05	0.68	0.68	1.36	0.45	6.79	1.81	2.49	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.38	7.56	0.87	0.00	0.29	0.00	4.07	0.29	2.62	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	5.85	1.35	0.00	0.45	0.45	4.50	2.25	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.00	14.09	0.95	0.54	1.76	0.81	8.26	3.25	2.17	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	9.76	0.51	0.00	0.51	0.51	5.65	0.51	2.05	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	7.76	2.12	0.00	0.00	0.00	4.94	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	18.66	8.66	0.00	0.67	0.67	0.00	3.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	8.15	1.53	0.00	0.51	1.02	7.13	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.87	7.74	1.07	0.53	0.80	0.27	2.40	1.33	1.87	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.09	9.83	1.89	0.19	0.57	0.19	7.75	1.51	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	11.04	1.84	0.00	0.61	1.23	3.07	1.84	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	18.75	9.79	0.82	0.00	0.00	0.00	4.89	2.45	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.00	7.50	1.67	0.21	0.62	0.21	2.92	0.83	1.25	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.81	6.73	1.96	0.28	0.00	0.28	3.08	1.40	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	11.33	1.03	0.00	1.03	0.00	6.18	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	10.16	0.87	0.58	0.87	0.00	4.64	1.16	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.67	7.47	0.90	0.30	0.00	0.00	3.59	0.90	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	6.64	1.11	0.00	0.00	0.55	1.66	1.66	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.50	15.20	2.12	1.41	1.06	0.71	6.36	1.41	1.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.91	8.48	0.37	0.74	0.00	0.74	6.27	0.74	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	8.06	0.00	0.00	0.00	0.00	8.06	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.50	9.59	0.77	0.00	1.54	0.38	4.22	1.92	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.68	13.59	0.57	0.57	2.26	0.57	3.96	0.57	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	11.49	2.46	0.82	0.82	0.00	1.64	0.00	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	12.65	1.36	0.00	0.90	0.45	4.97	2.71	2.71	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	6.46	1.44	0.00	0.72	0.00	5.03	0.72	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	10.46	2.99	2.24	1.49	0.00	5.98	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.07	11.15	1.86	1.11	0.74	0.37	5.57	1.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.21	6.46	1.29	0.43	0.00	0.43	2.15	1.29	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	10.28	1.71	0.00	0.86	0.00	4.28	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.33	11.99	2.00	1.00	0.33	0.67	6.00	0.67	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	9.65	0.60	0.60	1.21	0.00	7.84	2.41	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	9.24	2.13	0.00	0.71	0.00	4.98	3.55	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.53	9.97	1.37	0.69	0.34	0.34	4.47	1.72	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.03	7.51	1.07	0.00	0.00	0.00	7.51	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	10.77	2.02	0.00	0.67	1.35	8.08	3.37	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.15	10.74	1.48	0.37	0.74	0.00	2.59	1.11	2.59	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	3.49	3.49	0.00	2.33	0.00	3.49	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	8.46	0.00	0.00	0.00	0.00	3.17	5.29	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.81	14.01	0.40	0.40	1.20	0.40	6.80	1.20	3.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	13.81	0.73	0.73	0.00	0.73	8.00	1.45	3.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	21.46	9.20	0.77	0.77	1.53	0.00	11.50	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.17	10.36	1.48	0.00	0.99	1.48	3.45	0.99	3.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	9.41	0.00	0.00	0.00	0.00	4.70	0.94	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.13	11.56	1.01	0.50	1.51	0.50	10.56	2.01	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	13.97	1.80	0.45	1.35	0.45	4.96	1.80	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	15.49	0.00	0.00	3.44	0.00	8.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.93	18.26	1.34	0.89	0.00	0.00	7.57	2.67	2.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.38	14.47	3.13	1.17	0.39	0.78	5.08	2.74	2.74	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	8.58	1.98	0.66	0.66	0.66	5.94	0.66	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	17.64	0.52	0.52	0.52	0.52	5.71	3.11	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.38	12.69	0.00	0.44	0.88	1.31	3.06	0.88	2.19	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	5.59	1.12	0.00	1.12	0.00	5.59	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.34	12.81	2.65	0.44	1.32	0.44	4.86	2.21	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.81	11.96	0.77	0.39	1.16	0.00	6.56	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	7.09	1.52	0.00	2.03	0.51	5.57	1.01	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	9.61	1.44	0.48	0.48	0.00	7.21	1.92	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.53	9.54	2.78	0.40	0.40	0.00	7.95	2.78	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	15.19	0.61	0.61	0.00	0.00	4.86	1.82	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	11.76	2.08	0.69	0.00	0.00	6.23	0.69	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	13.68	2.28	0.76	0.76	0.00	9.12	1.14	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	12.39	1.55	0.00	0.00	0.00	6.20	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	9.07	1.21	0.60	0.00	0.00	0.00	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.89	11.73	1.27	0.00	0.63	0.32	6.02	1.27	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	17.06	1.60	0.53	0.53	0.00	5.86	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	14.94	2.87	0.00	0.00	0.00	2.30	2.87	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.43	13.88	0.51	0.51	1.03	0.00	5.66	1.54	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	10.61	4.24	0.00	1.41	0.00	6.37	0.71	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.92	19.86	1.70	0.57	0.00	0.57	4.54	1.13	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.31	11.23	0.83	1.25	0.42	0.42	7.07	2.50	2.08	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	13.31	0.78	0.00	2.35	0.78	3.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	14.61	1.67	0.84	0.42	0.42	4.18	2.51	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.37	11.62	0.93	0.46	1.39	0.00	5.58	2.32	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.05	8.03	2.01	1.34	2.01	0.00	3.35	0.67	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.71	13.90	1.60	1.07	0.53	0.53	4.28	1.60	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	22.23	12.93	1.21	0.40	1.62	0.40	5.25	2.02	2.42	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	11.01	1.84	0.00	2.75	0.00	7.34	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	10.67	0.89	1.78	0.89	0.89	4.45	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.21	17.67	1.71	0.00	0.57	1.14	2.28	1.71	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	11.50	0.77	0.00	0.77	0.00	8.44	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	16.42	1.64	0.00	0.55	0.55	3.28	1.64	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	11.14	4.01	1.78	1.78	0.45	5.79	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	22.36	14.56	3.12	1.04	1.04	0.00	4.16	1.04	2.60	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	16.58	3.98	0.00	0.66	0.00	3.98	2.65	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	18.71	2.08	4.16	0.00	0.00	4.16	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	4.33	5.24	2.28	0.23	0.23	0.00	1.82	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	2.20	3.30	2.20	0.18	0.00	0.00	2.75	0.37	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	2.23	4.98	2.23	0.13	0.00	0.13	2.62	0.39	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	2.66	0.53	0.53	0.53	1.06	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.29	5.86	1.43	0.48	0.16	0.00	1.27	0.00	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	4.86	7.23	2.08	0.69	0.00	0.56	1.39	0.42	0.69	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.77	6.98	0.80	0.10	0.40	0.10	1.69	0.40	0.80	0.00
Mammary Epithelial Cell, donor2	11350-117G9	9.84	2.61	1.16	0.29	0.00	0.00	1.16	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	9.23	2.24	1.75	0.25	0.00	0.00	1.00	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	49.49	18.30	5.42	2.03	1.36	2.03	10.85	2.03	2.03	0.00
Mast cell, donor1	11563-120D6	39.47	8.87	6.70	0.87	1.95	1.30	6.70	2.70	0.43	0.00
Mast cell, donor2	11565-120D8	21.40	5.05	4.16	0.89	0.89	0.30	5.35	1.19	0.59	0.00
Mast cell, donor3	11566-120D9	28.14	5.40	3.38	0.23	0.90	0.00	6.75	2.48	0.68	0.00
Mast cell, donor4	11567-120E1	20.92	4.08	3.90	0.00	0.00	0.35	5.67	2.13	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	22.07	13.20	10.42	1.00	0.33	0.55	5.88	1.44	0.22	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	9.92	8.76	8.17	1.17	0.00	1.17	1.17	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	23.86	12.62	7.11	0.80	0.46	0.46	6.08	1.03	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	9.71	6.19	6.86	0.67	0.50	0.67	6.19	0.50	1.17	0.00
Melanocyte - dark, donor1	11502-119F8	13.43	5.87	6.17	0.99	0.20	1.39	5.07	0.90	1.09	0.00
Melanocyte - dark, donor2	11582-120F7	6.58	3.46	2.77	1.38	0.00	0.00	3.81	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	20.72	5.22	6.52	0.51	0.80	0.14	4.78	1.30	1.74	0.07
Melanocyte - light, donor1	11274-116H5	7.99	7.76	4.00	1.18	0.00	0.71	4.23	1.18	1.88	0.00
Melanocyte - light, donor2	11351-117H1	10.24	9.55	6.14	1.36	0.00	0.68	4.78	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	5.20	1.73	2.60	0.87	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.89	2.71	3.75	0.62	0.31	0.10	2.39	0.42	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	7.26	2.15	4.57	0.81	0.00	0.81	1.61	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	12.32	5.36	9.11	1.07	0.27	0.54	2.68	0.80	0.80	0.00
Meningeal Cells, donor1	11493-119E8	40.07	8.44	13.89	1.36	0.62	0.99	7.20	1.49	1.74	0.00
Meningeal Cells, donor2	11573-120E7	36.53	4.40	7.48	4.40	0.44	0.00	7.48	0.88	0.88	0.00
Meningeal Cells, donor3	11654-122E7	24.61	4.65	8.56	2.28	0.98	0.82	3.91	0.82	1.39	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.25	5.13	4.56	0.86	0.00	0.29	4.28	0.57	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.15	7.45	4.33	0.91	0.10	1.01	3.52	0.60	0.91	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	13.14	6.57	1.31	0.00	0.00	13.14	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	5.23	1.31	5.23	0.00	0.00	6.54	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.05	4.31	2.15	0.72	0.00	0.00	2.15	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.89	5.72	1.91	0.42	0.21	0.00	3.39	1.06	1.06	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.03	4.52	5.03	0.50	0.50	0.00	3.02	1.01	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.32	6.81	7.91	2.42	1.10	0.22	7.47	1.10	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	6.58	3.65	2.92	0.00	0.00	4.38	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.98	5.32	5.32	1.84	0.61	0.61	5.73	1.23	1.23	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.45	7.89	5.12	1.52	0.55	0.28	11.22	2.22	1.66	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.38	11.52	7.06	1.49	0.74	1.86	8.18	1.49	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	7.37	9.21	4.08	1.05	0.66	0.00	7.89	0.53	1.45	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.95	13.35	5.04	0.59	0.00	0.89	6.23	0.89	5.34	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	11.68	0.00	2.34	2.34	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.21	7.68	3.20	0.64	1.92	0.64	7.68	2.56	3.20	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	8.15	6.73	6.38	0.71	0.00	1.42	1.42	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6.25	7.19	4.69	0.94	0.31	0.31	8.13	0.94	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	9.43	3.63	0.00	0.00	0.00	2.90	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	2.65	13.26	1.33	0.80	0.00	0.00	2.65	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	6.01	6.51	0.00	1.00	0.00	0.00	0.50	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.20	8.17	3.18	0.43	0.07	0.36	0.65	0.36	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	1.35	1.35	0.00	0.00	0.00	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.74	2.71	1.97	0.25	0.00	0.00	2.46	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	1.77	1.77	0.88	0.00	0.00	0.00	3.83	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.62	0.93	1.55	0.31	0.00	0.00	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.41	2.70	2.07	0.00	0.00	0.00	2.07	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.75	2.25	1.25	0.25	0.00	0.00	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	1.40	0.47	0.47	0.00	0.00	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.61	2.85	3.25	0.20	0.00	0.00	1.83	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1.19	2.38	0.79	0.00	0.00	0.00	2.77	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	5.31	0.88	0.00	0.00	0.00	3.54	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.38	3.80	0.76	0.00	0.00	0.38	3.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.21	2.12	1.49	0.42	0.00	0.21	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	1.84	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.89	0.89	1.19	0.00	0.00	0.00	0.89	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.75	1.25	0.75	0.00	0.00	0.00	2.01	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.43	2.14	0.24	0.00	0.00	0.00	2.61	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	1.11	0.00	0.00	0.00	0.00	1.11	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.46	1.38	1.38	0.00	0.00	0.00	1.84	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.68	1.68	0.63	0.21	0.00	0.00	2.31	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.41	1.63	1.02	0.20	0.20	0.00	0.82	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.43	2.57	1.29	0.00	0.00	0.00	1.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.89	1.56	0.89	0.00	0.00	0.00	1.56	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.22	0.66	0.44	0.22	0.00	0.22	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	0.51	0.51	0.00	0.00	0.00	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.00	1.63	0.54	0.00	0.00	0.00	1.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.88	1.18	0.29	0.00	0.00	0.00	0.59	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	0.96	0.48	0.00	0.00	0.00	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.00	2.40	0.00	0.80	0.00	0.00	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	2.50	1.00	0.00	0.00	0.00	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.88	0.44	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.50	0.74	1.24	0.25	0.00	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.34	1.37	0.68	0.00	0.00	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.44	0.88	0.88	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.56	1.40	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	2.08	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.60	0.30	0.60	0.30	0.00	0.00	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.42	0.42	1.25	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.92	0.92	0.00	0.92	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	1.14	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.97	0.97	0.69	0.00	0.00	0.00	0.14	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.26	1.30	0.26	0.00	0.00	0.00	1.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	0.43	0.43	0.00	0.00	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.27	1.07	0.53	0.27	0.00	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.90	1.80	0.90	0.00	0.00	0.00	1.20	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.42	0.99	0.42	0.14	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.32	1.27	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.66	0.88	0.44	0.00	0.00	0.00	1.33	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.14	2.28	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	0.28	0.00	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.98	0.74	0.25	0.49	0.00	0.00	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.88	2.65	1.18	0.29	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	0.58	0.86	0.29	0.00	0.00	1.15	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.06	4.12	0.41	0.00	0.41	0.00	1.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	1.19	1.49	0.00	0.00	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	5.35	0.00	0.00	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1.64	2.30	2.30	0.00	0.00	0.33	1.64	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	1.05	2.10	0.00	0.00	0.00	2.10	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1.78	1.58	2.17	0.20	0.00	0.20	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	1.86	1.86	0.00	0.93	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.38	3.00	1.13	0.00	0.00	0.00	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.33	1.33	1.60	0.00	0.27	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.36	1.24	1.36	0.11	0.00	0.11	0.34	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1.47	2.21	1.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.83	2.20	2.93	1.10	0.00	0.00	3.66	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	6.22	3.11	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	0.53	0.00	0.53	0.00	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	3.03	0.00	0.00	0.00	4.04	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.26	1.69	1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	4.09	1.36	0.00	0.00	0.00	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	4.53	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	22.84	0.00	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	29.36	0.00	0.00	0.00	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.40	2.80	3.66	1.08	0.00	0.43	1.51	0.43	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	4.18	4.18	0.52	0.00	0.52	4.18	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	0.00	1.33	1.33	0.00	0.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	0.83	1.67	0.00	0.42	0.00	0.83	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.99	2.28	4.37	0.57	0.00	0.00	0.76	0.38	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3.19	3.19	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	0.00	0.68	0.00	0.00	0.00	2.04	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	1.26	2.93	0.00	0.84	0.00	5.44	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.90	2.09	4.18	0.46	0.46	0.70	1.39	0.93	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.38	0.27	3.24	0.81	0.00	0.00	2.97	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.09	1.26	3.36	1.47	0.42	0.00	1.05	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	3.47	1.99	0.99	0.00	0.00	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	1.35	2.17	1.35	1.62	0.00	0.00	3.25	0.27	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.57	1.59	2.49	0.68	0.00	0.00	2.49	0.45	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.25	1.47	2.29	1.14	0.33	0.16	0.98	0.65	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	4.19	1.82	4.19	1.64	0.00	0.18	1.64	0.55	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	1.59	2.12	1.59	0.00	0.00	5.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	0.00	0.60	0.60	0.00	0.00	3.60	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.97	2.63	3.94	0.00	0.00	0.33	3.28	0.33	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.02	1.46	3.09	0.49	0.33	0.33	3.09	0.49	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	8.11	1.94	3.17	1.41	0.00	0.35	3.17	0.35	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	0.00	2.81	2.11	0.70	0.00	2.81	0.00	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	1.84	1.84	0.46	0.00	0.00	3.22	1.38	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3.21	0.32	1.61	1.29	0.00	0.00	3.86	0.64	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.79	0.69	2.41	0.34	0.00	0.00	2.07	0.00	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	7.59	2.53	2.53	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.46	0.89	2.45	1.11	0.00	0.22	1.56	0.22	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.93	3.39	2.12	0.00	0.00	0.42	1.69	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2.61	1.90	3.32	0.71	0.00	0.00	2.61	0.47	1.19	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	4.72	1.29	2.15	1.72	0.00	0.86	8.58	0.86	2.15	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.33	2.00	3.33	1.00	0.33	0.00	1.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.31	2.71	1.35	2.25	0.00	0.00	2.25	0.45	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	1.59	1.19	2.38	0.00	0.00	0.40	0.40	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	0.93	1.86	0.93	0.00	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.41	0.76	3.03	2.27	0.00	0.00	1.89	0.76	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.17	1.96	2.93	0.65	0.33	0.00	2.93	2.61	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	1.31	3.49	0.00	0.00	0.44	1.31	2.18	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	1.36	4.07	0.00	0.45	0.00	2.26	0.45	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	1.76	2.65	0.00	0.00	0.00	3.53	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	0.66	3.99	0.66	0.00	0.00	3.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	3.47	4.96	0.00	0.00	0.00	8.93	0.99	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	1.15	1.91	1.15	0.00	0.00	1.53	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	6.65	3.63	3.33	0.91	0.30	0.30	3.02	1.21	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.40	2.43	3.09	0.66	0.00	0.22	3.54	0.44	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	1.36	2.03	1.36	0.00	0.00	2.03	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	2.44	5.49	1.22	0.00	0.61	7.93	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	2.83	3.46	1.89	0.31	1.26	2.52	0.94	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.75	0.30	4.24	1.82	0.00	0.00	2.12	1.51	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	1.58	3.16	2.37	0.00	0.00	3.96	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	3.40	2.27	1.13	0.00	0.00	2.27	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.46	3.85	1.86	1.49	0.37	0.25	1.12	0.50	0.25	0.00
Myoblast, donor2	11322-117D8	7.10	5.56	2.88	1.34	0.19	0.00	2.69	0.00	0.38	0.00
Myoblast, donor3	11398-118D3	9.42	4.37	5.55	1.85	0.17	0.50	6.05	0.67	1.01	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.83	7.30	6.86	1.17	0.29	0.44	4.67	3.50	1.17	0.00
Natural Killer Cells, donor1	11230-116C6	7.07	5.54	1.54	0.31	0.62	0.00	1.54	0.31	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	5.13	7.84	2.71	0.60	0.00	0.00	4.52	0.60	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	5.15	6.81	3.13	0.18	0.18	0.37	2.39	0.74	0.37	0.18
Neural stem cells, donor1	11275-116H6	59.16	3.27	5.81	2.90	2.18	0.00	4.36	0.73	2.18	0.00
Neural stem cells, donor2	11352-117H2	121.32	7.70	17.33	0.00	3.85	0.00	5.78	0.00	3.85	0.00
Neurons, donor1	11494-119E9	67.14	1.14	11.38	2.28	2.28	0.00	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	73.97	2.20	12.55	2.20	2.20	0.22	3.08	1.10	0.00	0.00
Neurons, donor3	11655-122E8	49.33	0.82	2.47	0.82	4.11	0.00	4.11	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	13.89	9.02	10.80	5.82	0.36	0.95	11.64	1.07	2.97	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	4.56	9.44	2.93	0.65	0.65	10.74	0.33	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	5.62	2.41	3.61	0.20	0.60	0.20	3.61	0.60	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	1.93	2.75	2.62	0.83	0.28	0.00	1.93	0.41	0.69	0.00
Olfactory epithelial cells, donor2	11934-125I8	5.07	2.75	3.04	0.72	0.14	0.14	1.45	0.43	0.87	0.00
Olfactory epithelial cells, donor3	11935-125I9	5.90	6.36	5.11	1.70	0.00	0.11	3.86	1.25	1.59	0.00
Olfactory epithelial cells, donor4	11936-126A1	7.60	3.31	4.68	1.56	0.68	0.00	2.53	0.58	1.07	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	18.05	6.62	3.01	0.00	1.20	0.60	5.42	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.63	4.89	4.25	0.64	0.43	0.64	5.53	1.91	2.77	0.00
Osteoblast - differentiated, donor2	11353-117H3	11.43	2.29	2.29	1.14	0.00	0.00	4.57	2.29	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.21	2.48	0.62	2.48	0.00	1.24	3.10	0.00	1.24	0.00
Osteoblast, donor1	11277-116H8	16.61	4.50	5.86	2.35	0.20	0.39	5.47	0.98	1.37	0.00
Osteoblast, donor2	11354-117H4	14.75	2.11	2.11	2.11	0.70	0.00	2.11	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	13.15	2.84	4.09	1.42	0.18	0.00	1.78	0.53	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	10.02	5.31	5.48	1.60	0.25	0.17	3.45	0.84	1.35	0.00
Pericytes, donor1	11491-119E6	25.70	5.12	8.01	2.00	1.22	0.56	8.90	3.34	2.34	0.00
Pericytes, donor2	11571-120E5	23.99	4.75	6.56	2.04	0.45	0.91	9.05	1.81	1.58	0.00
Pericytes, donor3	11652-122E5	15.46	6.51	2.64	0.61	2.03	1.02	5.70	1.02	1.02	0.00
Perineurial Cells, donor1	11499-119F5	16.95	6.44	7.57	2.26	0.23	0.57	7.12	1.36	1.36	0.00
Perineurial Cells, donor2	11579-120F4	9.48	3.40	3.96	1.38	0.00	0.64	4.23	0.74	0.46	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	8.92	10.20	2.87	0.00	0.32	0.00	0.96	0.64	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	3.43	6.12	1.22	0.24	0.00	0.00	2.20	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.95	8.02	1.94	0.26	0.00	0.00	2.46	0.26	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	21.52	4.30	3.35	0.48	0.72	0.00	1.43	0.72	0.96	0.00
Placental Epithelial Cells, donor2	11355-117H5	23.29	7.76	5.54	0.00	1.11	0.00	3.33	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	27.68	4.52	6.09	1.57	1.18	0.59	8.25	1.37	1.18	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.70	2.53	2.85	0.00	0.32	0.00	4.11	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	5.82	2.44	2.06	1.13	0.19	0.56	3.00	0.19	0.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.96	3.79	4.31	0.39	0.13	0.26	2.35	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	3.83	2.70	3.38	1.80	0.68	0.23	4.95	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	4.80	4.90	2.77	0.75	0.11	0.21	4.80	0.43	1.49	0.00
Preadipocyte - omental, donor2	11329-117E6	6.55	4.36	5.67	2.62	0.00	0.87	7.42	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	9.45	3.58	4.30	1.15	0.72	1.15	2.72	0.86	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.00	0.98	0.98	0.00	0.00	5.91	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.13	3.69	6.76	1.84	0.61	0.61	5.22	0.61	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	8.85	3.90	3.36	1.77	0.18	0.35	3.19	0.53	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	8.17	1.87	2.89	0.34	0.00	0.34	1.70	0.17	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.13	3.63	3.54	0.47	0.37	0.47	2.98	0.28	0.93	0.00
Preadipocyte - visceral, donor2	11357-117H7	12.42	3.22	3.68	0.92	0.92	1.38	1.38	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.42	2.19	1.57	0.84	0.10	0.31	1.99	0.21	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	6.94	2.87	2.56	1.51	0.00	0.30	1.96	0.60	0.75	0.00
Prostate Epithelial Cells, donor2	11331-117E8	14.22	12.19	1.49	0.14	0.68	0.41	0.95	0.68	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	8.14	7.78	0.61	0.12	0.12	0.18	0.92	1.04	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	10.02	4.21	1.71	1.03	0.34	0.23	1.25	0.46	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	8.25	6.81	3.59	3.59	0.18	0.36	3.41	0.36	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	8.24	6.05	3.65	1.25	0.21	0.52	5.63	0.73	1.15	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	8.39	3.65	0.00	0.73	0.00	6.57	2.19	1.46	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.73	9.22	2.29	0.42	0.55	0.49	3.67	1.80	0.62	0.00
Renal Epithelial Cells, donor1	11517-119H5	39.06	11.16	7.10	2.54	0.00	0.51	6.09	1.01	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	4.98	0.00	0.00	0.00	0.00	4.27	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	13.87	11.75	3.18	0.74	0.00	0.64	5.93	0.53	0.95	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	1.36	4.09	0.00	0.00	0.68	3.40	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.94	4.45	3.10	0.27	0.13	0.27	2.16	0.67	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.10	4.00	2.22	0.67	0.22	0.22	1.11	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	16.64	7.99	8.65	1.33	0.00	2.00	3.99	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	21.35	9.02	5.72	2.20	0.00	0.22	8.14	0.88	1.76	0.00
Renal Mesangial Cells, donor2	11598-120H5	24.45	6.27	5.64	0.00	0.63	0.00	7.52	1.25	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.03	6.38	5.55	2.50	0.28	0.28	6.10	1.39	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.01	6.17	4.29	0.54	0.27	0.54	1.88	0.54	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	4.22	1.27	0.84	0.84	0.00	1.69	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.48	5.59	3.86	0.58	0.39	0.19	2.89	0.77	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.67	6.48	6.22	1.30	1.81	0.78	4.93	1.04	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.46	7.96	13.36	1.99	0.57	1.14	5.12	0.57	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	6.17	6.17	3.09	0.00	0.00	6.17	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.81	14.30	6.52	1.76	0.50	0.75	2.26	0.25	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	11.09	12.43	8.29	2.14	0.53	0.40	5.35	0.94	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	11.61	0.89	4.47	0.89	0.89	0.00	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	2.75	8.26	1.10	0.00	0.00	1.65	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	4.06	8.12	0.58	0.00	0.00	4.06	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.14	3.25	4.16	1.04	0.00	0.13	1.95	0.39	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.51	3.97	4.67	1.29	0.50	0.10	3.28	0.79	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.60	3.90	5.13	1.67	0.67	0.33	3.68	1.23	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	11.78	2.60	5.09	1.74	0.12	0.50	1.74	0.62	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.70	3.38	6.41	1.05	0.47	0.35	2.56	1.28	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	19.42	4.39	5.78	2.08	0.92	0.46	2.31	0.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.86	2.19	4.38	0.96	0.41	0.14	0.96	1.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.59	2.42	5.75	0.91	0.45	0.45	1.66	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	12.36	3.76	5.20	1.79	0.54	0.18	1.97	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.91	2.01	4.02	1.29	0.29	0.14	2.30	1.58	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.02	2.47	6.33	0.97	0.54	0.11	2.58	0.43	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	13.28	3.32	5.53	1.11	0.89	0.22	2.43	0.89	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.84	4.78	3.25	1.34	0.19	0.00	2.49	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.90	2.89	4.47	1.30	0.84	0.09	2.33	1.02	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	16.72	2.82	6.01	2.25	0.19	0.75	3.19	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.69	3.18	4.25	0.93	0.27	0.27	1.86	1.73	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.50	2.24	5.26	1.17	0.58	0.10	2.14	1.17	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.75	4.01	8.02	0.95	0.57	0.38	3.82	1.34	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	9.72	2.14	4.06	0.96	0.11	0.21	1.71	0.96	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.05	4.20	4.20	0.56	0.28	0.28	2.52	1.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.53	2.56	4.96	1.37	0.85	0.17	2.05	0.51	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	2.92	3.83	1.09	0.55	0.18	1.82	1.28	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.88	2.45	5.52	1.35	0.74	0.25	2.45	1.10	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.91	4.43	6.72	2.42	0.94	0.27	3.49	0.94	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.27	4.01	4.01	0.47	0.71	0.00	0.94	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	15.08	3.77	4.37	0.99	0.40	0.60	2.98	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.26	3.51	8.65	2.57	0.70	0.23	2.81	0.94	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.82	3.11	4.56	0.83	0.83	0.00	1.45	1.04	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	12.83	3.32	4.87	1.11	0.44	0.00	1.55	0.88	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.28	4.18	7.10	2.09	0.42	0.21	1.46	0.42	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.71	4.04	4.71	0.94	0.13	0.67	1.75	1.35	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.41	2.21	6.47	1.87	0.34	0.17	2.21	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	13.11	3.86	9.64	1.54	0.96	0.00	2.51	0.19	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.49	3.61	7.22	2.06	0.52	0.00	2.58	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.19	3.43	4.66	0.55	0.27	0.14	2.74	0.69	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.19	3.45	6.57	1.48	0.49	0.16	2.46	0.16	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.01	4.09	4.26	1.19	0.17	0.17	2.39	1.02	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	13.02	3.26	6.07	1.63	0.89	0.30	3.40	1.92	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.40	3.47	5.06	1.07	0.53	0.00	3.20	0.80	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.76	1.94	4.70	0.97	1.11	0.00	1.94	1.24	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.95	3.33	7.38	1.43	0.95	0.24	1.67	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	21.16	6.05	9.27	3.02	1.21	0.20	4.64	1.41	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	11.77	3.01	4.33	0.57	0.47	0.09	2.17	1.13	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.02	5.24	7.69	3.14	0.35	1.05	3.49	2.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.90	2.72	6.04	3.02	0.00	0.00	3.32	1.51	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.87	2.33	4.90	1.84	0.49	0.24	2.33	1.22	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.96	8.73	11.94	7.42	0.15	0.44	4.95	1.60	0.87	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.64	1.83	5.48	3.04	0.00	1.83	4.87	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.36	2.11	4.52	1.81	0.30	0.30	3.62	1.51	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	14.70	3.62	6.11	3.85	0.45	0.45	4.30	1.58	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	22.47	7.79	10.48	1.50	0.30	0.30	5.99	3.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.17	5.79	6.26	2.36	0.24	0.24	2.72	1.77	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.94	4.48	6.19	1.71	0.85	0.21	3.63	1.71	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.23	3.61	4.81	2.40	0.60	0.00	5.41	1.20	1.20	0.00
Schwann Cells, donor1	11498-119F4	28.40	5.64	5.64	1.13	1.69	0.38	4.33	1.88	0.56	0.00
Schwann Cells, donor2	11578-120F3	13.61	6.80	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.65	3.94	4.16	0.88	0.44	0.44	4.16	0.66	0.66	0.00
Sebocyte, donor1	11220-116B5	33.41	25.20	7.67	1.10	1.64	2.19	3.83	1.64	2.19	0.00
Sebocyte, donor2	11301-117B5	11.95	17.46	5.06	2.76	0.46	0.00	3.22	0.00	2.30	0.00
Sebocyte, donor3	11378-118B1	15.66	14.63	5.36	1.24	1.44	0.00	7.01	2.27	0.62	0.00
Sertoli Cells, donor1	11255-116F4	6.63	8.28	0.00	1.66	0.00	0.00	6.63	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	2.82	2.82	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.81	5.37	6.77	2.02	1.32	0.62	3.08	0.97	0.88	0.00
Skeletal Muscle Cells, donor2	11358-117H8	6.51	2.17	5.78	0.72	0.00	0.00	2.89	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	0.00	7.52	3.34	0.84	0.00	5.85	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.78	3.61	3.61	1.73	0.31	0.31	3.46	0.47	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	9.81	3.12	3.57	1.64	0.30	0.45	3.86	0.59	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	9.70	3.69	4.31	1.85	0.00	0.77	2.77	0.62	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.23	8.19	8.69	1.51	0.63	1.13	11.34	2.39	2.14	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.41	7.28	6.14	1.85	0.00	0.43	8.13	0.86	1.28	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	20.24	4.07	5.06	2.38	0.60	0.50	2.88	1.19	0.79	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.90	5.14	6.82	1.77	1.43	0.59	4.89	1.18	1.35	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	3.62	3.62	1.45	1.45	0.00	4.34	2.17	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.91	2.06	2.61	0.28	0.41	0.00	1.65	0.28	0.28	0.00
Skin - palm, donor1	10286-104F7	10.74	5.37	2.69	0.00	2.69	0.00	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.24	5.91	1.01	0.72	0.14	0.29	0.43	0.43	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	37.62	42.53	9.81	1.64	3.27	0.00	0.00	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.09	4.80	1.56	0.13	0.52	0.13	1.56	0.39	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	13.62	9.17	0.83	0.83	0.28	0.28	1.53	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.27	3.80	1.41	0.70	0.42	0.14	1.13	0.42	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	36.58	13.74	7.61	1.27	0.85	0.85	4.86	1.90	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	10.19	10.19	0.90	0.22	0.30	0.15	1.12	1.20	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	5.86	1.54	0.62	0.00	0.62	4.01	1.23	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.11	7.78	2.22	0.89	0.44	0.00	1.56	0.67	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	7.64	4.11	1.18	0.00	0.00	7.05	0.59	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.20	3.76	1.77	0.66	0.00	0.22	2.87	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.66	5.51	2.36	0.39	0.39	0.39	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	3.86	0.77	2.32	0.00	0.00	4.64	3.86	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	5.00	13.01	3.00	1.00	0.00	6.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.99	5.19	2.93	0.93	0.00	0.80	4.66	0.67	1.60	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.31	1.55	1.77	0.44	0.22	0.00	3.99	0.66	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	2.94	5.51	1.15	0.38	0.13	0.64	1.28	0.26	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.70	3.58	5.54	1.30	0.00	0.98	3.26	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.24	3.84	4.73	1.48	0.59	0.30	7.38	0.59	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.55	4.70	1.42	0.57	0.28	0.57	3.42	0.85	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.98	7.65	6.02	2.44	0.49	0.81	5.53	2.11	0.98	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.05	5.48	1.83	3.04	0.30	0.30	1.52	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.31	2.78	5.56	1.26	0.51	0.00	5.56	1.01	2.53	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	2.38	1.43	0.48	0.00	0.00	2.38	0.95	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.21	4.13	5.90	1.77	0.44	0.15	2.51	0.88	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.34	4.30	3.01	0.65	0.86	0.00	1.94	0.65	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.65	4.09	4.09	1.26	0.42	0.31	2.52	0.73	0.84	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.37	6.19	1.86	0.77	0.62	0.62	3.09	0.31	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	7.55	2.16	2.16	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.18	2.09	1.79	0.90	0.00	0.00	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.34	8.19	6.49	2.39	0.34	0.68	6.15	1.71	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.34	8.09	7.30	2.91	0.16	1.02	6.99	1.02	1.57	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.27	6.04	2.62	1.01	0.50	0.00	6.44	0.60	1.01	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.96	5.92	3.87	1.37	0.00	0.91	2.50	0.68	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	4.83	3.62	0.00	0.00	0.60	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.84	6.62	5.56	2.38	0.00	1.85	1.85	1.85	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.52	3.60	3.33	0.93	0.40	0.67	3.06	0.93	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.39	6.26	2.13	1.13	0.00	0.25	3.38	0.88	1.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.60	2.54	2.79	1.01	0.51	0.51	4.31	1.78	1.78	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.35	3.32	2.11	0.60	0.15	0.60	1.51	0.45	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	3.00	0.75	0.00	0.75	0.75	0.75	0.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.91	3.26	2.33	1.86	0.00	0.00	5.58	1.86	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	6.56	0.50	1.51	0.00	1.01	4.04	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.70	8.15	0.94	0.63	0.63	0.31	3.76	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.93	8.85	3.54	1.77	0.29	0.59	14.16	1.47	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.49	5.50	5.66	2.75	0.67	0.50	4.08	1.08	1.58	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	4.20	4.67	2.80	0.00	0.00	3.74	0.93	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.65	6.62	2.73	1.73	0.14	0.58	4.03	0.86	0.86	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.77	6.37	3.82	0.51	0.25	0.51	3.06	0.51	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.72	3.20	2.63	0.19	0.38	0.19	1.69	0.94	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.44	7.41	5.59	0.42	0.42	0.42	5.45	1.12	1.12	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.89	8.38	4.19	0.84	0.25	0.17	5.78	1.34	0.75	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	5.71	2.38	0.48	0.00	1.43	7.62	2.38	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.92	7.83	3.43	0.73	0.00	0.24	2.94	0.98	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.06	3.54	2.87	0.66	0.44	0.00	3.09	1.10	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.19	1.76	3.51	0.88	0.29	0.29	1.46	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.94	3.89	4.47	0.58	0.39	0.19	1.55	0.58	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	6.35	1.59	0.26	0.53	0.26	1.59	0.00	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	6.32	2.98	0.74	0.00	0.00	2.23	0.00	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.01	10.06	3.23	0.72	0.72	0.00	5.03	1.44	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.39	6.53	1.14	0.28	0.00	0.00	2.27	0.85	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.67	3.94	2.76	1.18	0.39	0.00	3.54	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	5.33	4.83	0.76	1.02	0.25	0.25	0.00	0.00	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.59	4.39	1.20	0.40	0.00	0.00	1.60	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	4.18	2.09	1.25	0.00	0.42	0.00	4.18	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.50	4.13	2.75	0.92	0.00	0.92	2.29	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	3.03	2.02	1.01	1.01	0.17	0.17	3.20	0.00	0.50	0.00
Synoviocyte, donor2	11368-117I9	9.55	1.84	3.02	0.67	0.34	0.00	3.86	0.67	0.84	0.00
Synoviocyte, donor3	11440-118H9	6.03	0.89	3.13	0.89	0.45	0.22	2.68	0.89	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	37.88	6.43	14.29	2.50	0.71	0.36	3.22	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	15.86	9.91	1.98	0.00	0.00	3.96	1.98	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.54	5.33	7.64	2.08	1.16	0.00	5.09	1.85	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	12.40	5.95	2.08	0.65	0.65	0.29	1.65	0.65	0.50	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	4.25	3.09	0.77	0.00	0.00	0.39	0.77	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	3.44	0.00	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.33	10.46	7.87	2.46	0.86	0.00	8.12	1.11	0.74	0.00
Urethra, donor2	10319-105A4	16.19	8.99	1.80	0.00	1.80	0.00	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	11.69	2.39	0.53	0.00	0.27	2.92	0.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	10.01	12.42	3.20	0.40	0.00	0.40	5.21	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	13.52	7.11	2.29	0.23	0.00	0.23	2.75	2.52	0.23	0.00
Urothelial cells, donor0	11216-116B1	14.93	8.02	3.12	0.22	0.67	0.22	6.24	1.56	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	11.57	12.46	2.67	0.89	0.00	0.00	5.34	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	8.58	2.86	0.00	0.00	0.00	5.72	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	6.85	0.00	0.00	0.00	0.00	2.05	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	7.58	15.50	4.13	0.00	0.00	0.34	2.75	0.34	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	6.97	12.20	1.74	0.00	0.00	0.00	4.07	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	6.25	3.12	0.00	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	11.93	4.59	0.92	1.84	0.00	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	8.22	1.83	0.00	0.00	0.00	3.65	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	20.11	6.91	10.12	6.41	0.25	1.23	4.69	0.86	0.74	0.12
Wilms' tumor cell line:HFWT	10597-108E3	15.84	2.64	0.00	2.64	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.98	1.12	1.96	0.56	0.56	0.00	5.03	1.40	1.12	0.00
achilles tendon, donor2	10292-104G4	4.13	8.27	4.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	14.53	3.31	4.59	4.08	1.02	0.25	5.35	0.51	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	7.43	3.71	16.02	2.32	0.00	0.23	1.16	0.23	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	25.76	13.06	12.82	5.34	0.00	1.42	4.27	1.07	0.95	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	39.18	11.43	12.52	3.27	1.09	1.90	4.63	0.54	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	28.95	4.78	3.65	1.69	0.00	0.28	1.97	0.56	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	14.59	6.56	6.56	2.96	0.42	0.63	5.50	0.00	1.27	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.62	1.36	2.99	0.27	0.27	0.54	1.63	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	14.10	2.64	8.81	2.64	0.44	1.32	3.97	0.44	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.62	5.72	12.66	1.63	0.41	1.23	8.98	1.23	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.58	2.33	13.59	0.39	0.39	0.00	4.66	3.11	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.10	2.76	4.23	0.55	0.55	0.37	0.18	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	0.00	3.90	0.00	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.94	3.49	6.74	1.16	1.39	0.23	7.44	1.39	1.63	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	14.50	4.14	3.37	1.04	0.26	0.00	0.52	0.00	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.97	2.34	3.21	1.17	0.58	0.00	1.17	0.00	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	5.58	4.65	2.79	0.46	0.93	0.00	1.86	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3.70	2.06	7.81	1.23	0.00	0.00	2.88	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.37	1.23	1.84	0.00	0.31	0.31	1.23	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.37	3.41	3.41	0.43	0.00	0.00	1.71	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	3.03	2.73	1.82	0.61	0.00	1.21	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	8.18	2.89	2.41	0.72	0.24	0.48	1.20	0.24	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.82	9.58	4.45	1.56	0.67	0.22	0.67	0.22	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.02	16.34	3.67	2.00	0.33	0.67	6.34	1.00	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	0.00	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.73	4.14	3.39	2.26	0.38	0.38	3.39	0.75	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	25.73	2.18	8.29	1.31	0.87	0.44	2.62	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	7.50	3.75	1.87	0.00	0.00	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	6.36	6.83	5.42	1.65	0.71	0.24	5.18	0.94	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	9.31	9.46	6.36	0.93	0.16	0.78	9.00	0.78	1.24	0.00
adipose, donor1	10184-103D4	17.01	4.10	4.10	0.59	0.00	0.00	2.93	2.35	0.59	0.00
adipose, donor2	10185-103D5	28.39	2.03	5.68	0.81	2.43	0.41	4.87	1.22	0.81	0.00
adipose, donor3	10186-103D6	31.31	4.36	6.26	0.82	2.18	0.00	3.81	1.36	0.27	0.00
adipose, donor4	10187-103D7	20.80	3.47	1.73	1.73	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.62	7.26	4.89	0.63	0.79	0.47	3.16	2.84	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	0.00	14.55	7.28	3.64	0.00	0.00	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.67	4.67	5.07	1.73	0.53	0.13	5.47	1.47	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	4.64	2.86	6.43	2.50	0.00	0.36	3.57	0.00	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	14.84	3.25	1.39	0.00	0.23	0.00	3.71	1.62	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	16.91	5.41	3.38	0.34	1.01	0.00	6.76	2.37	2.03	0.00
amniotic membrane cells, donor3	12237-129G5	11.19	4.12	1.18	0.00	0.59	0.29	7.95	4.12	0.88	0.00
amygdala - adult, donor10196	10167-103B5	15.42	7.11	8.30	2.37	1.19	1.19	8.30	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	38.12	12.17	16.83	2.84	2.23	0.61	17.24	4.06	2.43	0.00
amygdala, newborn, donor10223	10360-105E9	15.17	8.71	6.78	1.29	0.32	0.32	4.20	0.65	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	10.95	1.15	2.67	0.13	0.89	0.38	7.13	1.15	1.02	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.37	2.87	1.10	0.44	0.00	0.22	0.88	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.74	4.68	14.70	2.34	1.00	0.33	8.68	3.67	1.00	0.00
aorta, adult, pool1	10052-101G7	17.26	6.86	5.69	0.39	0.00	0.20	8.63	1.57	0.98	0.00
appendix, adult	10189-103D9	9.70	11.26	5.43	1.16	0.00	1.16	5.05	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	6.53	3.78	4.82	0.00	0.34	1.03	2.75	1.38	0.69	0.00
artery, adult	10190-103E1	13.59	1.36	2.72	2.72	0.00	0.00	10.87	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	13.47	5.07	5.07	2.46	0.87	0.29	5.79	1.30	0.87	0.00
b cell line:RPMI1788	10427-106D4	19.78	4.46	2.53	1.19	1.34	0.45	6.10	1.93	0.59	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.05	3.61	2.77	0.55	0.28	0.28	4.44	1.39	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.31	3.27	1.29	0.60	0.40	0.10	1.39	0.60	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	4.18	10.21	0.50	0.00	0.33	0.50	0.84	0.84	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	4.47	0.56	2.24	2.24	0.00	2.24	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	14.34	7.06	4.56	0.33	0.33	0.11	8.47	0.98	1.85	0.00
blood, adult, pool1	10053-101G8	2.21	2.21	2.21	0.00	0.00	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	0.86	5.14	0.00	0.00	0.00	4.28	1.71	0.86	0.00
bone marrow, adult	10192-103E3	7.42	8.10	3.37	4.72	0.67	0.00	5.40	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	18.45	4.10	10.25	2.05	3.08	0.00	24.60	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	14.59	8.24	11.36	2.56	0.67	1.22	25.39	1.45	3.12	0.00
brain, fetal, pool1	10085-102B4	58.77	2.67	37.40	0.00	0.00	2.67	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	23.46	6.61	0.00	0.33	1.32	0.00	2.64	1.98	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	15.98	5.24	2.37	0.25	1.37	0.25	3.50	2.25	0.75	0.00
breast, adult, donor1	10080-102A8	10.10	3.16	6.31	2.53	0.63	0.63	1.26	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.20	10.16	9.40	3.30	0.38	1.02	4.95	1.91	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.08	5.88	3.40	0.62	0.31	0.00	2.47	2.16	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.98	5.30	5.30	0.46	0.00	0.92	10.36	0.23	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.05	5.57	3.15	0.00	0.00	0.48	3.39	1.45	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	42.32	5.64	11.75	7.52	1.41	0.47	11.75	3.29	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	11.92	5.91	1.86	0.44	0.55	0.11	3.17	1.09	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	12.04	2.22	2.85	2.85	0.32	0.00	7.92	3.17	1.27	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.82	2.93	7.19	2.66	0.53	0.53	6.12	1.06	1.86	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	14.97	11.51	1.15	2.30	0.00	16.12	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	41.16	14.06	14.22	2.51	2.84	0.84	13.72	3.01	2.01	0.00
caudate nucleus, adult, donor10258	10379-105H1	25.98	8.41	4.58	0.00	3.06	1.53	15.28	3.06	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	24.54	7.69	6.59	2.20	0.73	1.10	3.66	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	43.70	5.83	11.65	5.83	0.00	0.00	23.31	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	49.11	8.75	29.25	3.42	3.20	0.85	10.89	1.71	1.71	0.00
cerebellum, adult, pool1	10083-102B2	19.32	4.48	11.38	1.38	1.72	0.00	9.31	1.72	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	34.87	10.79	13.28	6.64	0.00	0.00	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	7.56	3.28	4.03	1.26	0.25	0.76	13.87	1.01	1.51	0.00
cerebrospinal fluid, donor2	10294-104G6	6.58	0.73	1.46	0.00	0.73	0.00	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.69	10.06	2.88	1.01	0.86	0.43	2.73	0.86	1.44	0.00
cervical cancer cell line:ME-180	10553-107I4	33.14	2.32	2.32	0.66	0.99	0.33	4.14	2.32	1.16	0.00
cervix, adult, pool1	10013-101C4	22.26	5.67	5.25	1.26	1.05	0.31	5.46	1.15	1.47	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.31	0.28	0.98	0.14	0.14	0.28	3.62	0.56	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	0.00	0.00	0.00	0.00	0.00	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.01	4.35	2.73	0.37	0.12	0.00	4.10	1.86	3.23	0.00
choriocarcinoma cell line:SCH	10785-110H2	7.39	5.05	2.09	0.49	0.62	0.25	3.82	0.99	0.49	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	14.71	6.40	1.90	0.00	1.19	0.47	1.42	0.71	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	9.40	3.42	1.71	0.57	1.14	0.57	2.56	1.71	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	11.43	1.99	3.18	0.60	0.30	0.20	1.99	0.89	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	3.85	2.75	1.65	0.00	0.00	0.00	2.20	1.65	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	12.12	3.03	0.00	0.00	0.00	4.04	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	11.72	2.50	5.76	0.38	0.58	0.00	4.42	0.19	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.88	2.11	4.86	1.27	0.21	0.00	3.17	1.06	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	19.00	9.50	6.42	1.54	0.51	0.51	1.54	0.51	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.12	11.85	8.22	1.45	0.00	0.73	1.21	1.69	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	29.93	9.98	6.11	1.63	0.81	0.41	1.43	0.00	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	21.50	4.12	9.42	1.77	0.00	0.59	1.18	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.52	6.78	8.86	2.35	0.00	0.26	3.13	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.89	2.51	2.51	0.46	0.00	0.23	11.89	1.14	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	6.42	3.47	2.60	0.35	0.35	0.17	4.86	1.21	1.74	0.00
colon carcinoma cell line:CACO-2	10513-107D9	5.86	1.46	3.84	0.37	0.37	0.37	1.28	0.18	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	33.83	14.82	39.15	9.50	1.52	0.76	14.06	4.18	3.42	0.00
colon, adult, donor1	10082-102B1	19.04	14.28	11.90	2.38	0.00	0.00	5.95	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	7.76	5.76	4.70	0.35	0.47	0.24	4.47	0.47	0.71	0.00
colon, fetal, donor1	10070-101I7	8.65	4.94	1.85	0.00	0.00	0.62	2.47	1.85	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	36.67	4.58	4.58	0.00	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	22.52	5.10	2.97	4.25	0.85	1.27	1.70	0.42	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	15.09	4.38	7.55	2.87	0.45	0.75	3.77	0.15	1.81	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	18.90	7.47	8.60	4.23	0.71	1.13	2.54	0.71	1.69	0.00
corpus callosum, adult, pool1	10042-101F6	51.19	18.35	17.03	4.31	2.99	1.88	25.21	3.10	6.41	0.00
cruciate ligament, donor2	10295-104G7	8.10	0.81	0.81	0.00	0.00	0.00	0.81	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	8.03	1.61	2.41	0.80	0.00	0.00	2.41	0.80	0.80	0.00
diencephalon, adult	10193-103E4	13.68	5.76	6.72	2.16	1.44	0.96	15.84	0.72	2.16	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.70	7.35	7.35	2.07	0.23	0.46	4.36	1.15	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.95	6.15	2.31	1.03	0.51	0.00	7.44	1.03	3.85	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.91	3.37	1.20	1.20	1.44	1.44	3.61	2.17	2.41	0.00
ductus deferens, adult	10196-103E7	18.44	15.95	7.48	3.49	1.00	0.50	5.98	3.49	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	11.52	1.44	5.76	0.00	0.00	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	5.15	8.09	0.74	0.00	0.00	1.47	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	13.79	4.87	3.88	0.66	0.83	0.41	4.87	1.07	0.83	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	37.09	11.33	3.11	18.21	1.55	0.44	1.55	0.22	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	40.55	9.74	9.74	8.17	2.29	0.72	2.01	0.29	1.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	3.08	1.23	1.85	0.00	0.00	0.00	1.85	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	5.75	6.66	4.24	0.91	0.00	0.00	1.82	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	6.17	3.70	2.47	0.93	0.00	0.00	0.62	0.62	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	3.69	6.70	10.73	2.35	0.34	0.67	0.67	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	5.98	3.08	6.34	0.54	0.36	0.00	1.27	0.18	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.28	4.82	1.93	0.32	0.48	0.32	3.22	0.64	0.80	0.00
epidermoid carcinoma cell line:A431	10426-106D3	28.35	3.33	3.78	1.89	1.22	0.33	5.78	2.00	2.45	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.31	5.28	2.31	0.55	1.21	0.11	7.92	2.64	1.87	0.00
epididymis, adult	10197-103E8	13.40	6.28	5.02	0.84	0.63	0.42	6.49	0.42	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.23	5.14	3.73	0.71	0.18	0.00	7.10	1.60	0.53	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.15	1.18	1.57	0.00	0.39	0.00	1.18	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	8.91	7.08	6.68	1.83	0.39	0.66	1.70	0.26	1.18	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.43	8.66	8.76	3.44	0.10	0.69	4.04	0.30	1.87	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.61	8.96	10.64	3.92	0.45	0.34	2.35	0.22	0.90	0.00
esophagus, adult, pool1	10015-101C6	23.57	8.28	3.61	0.85	1.49	0.53	4.03	0.53	0.74	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	27.68	16.53	12.65	2.50	0.13	1.63	2.25	0.75	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	9.66	4.83	2.41	0.00	2.41	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	2.10	0.00	0.00	0.00	0.00	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	5.95	1.49	2.98	0.00	0.00	0.00	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	3.44	1.15	4.59	0.00	1.15	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	1.46	0.00	0.00	1.46	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	23.90	4.07	8.90	1.02	1.02	0.00	6.36	1.78	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	7.95	1.41	1.92	0.38	0.13	0.38	2.05	0.38	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.26	1.90	3.09	0.95	0.00	0.00	1.90	0.95	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	24.49	9.57	14.82	2.25	0.66	1.41	24.11	2.16	2.06	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.21	3.60	3.60	0.60	0.60	0.90	0.90	0.60	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.33	22.04	6.22	0.64	1.10	0.55	13.53	3.75	0.82	0.00
gall bladder, adult	10198-103E9	18.11	8.69	6.76	0.00	0.48	0.00	5.31	0.72	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	9.13	9.13	5.37	0.00	0.00	0.00	3.76	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	12.33	11.95	1.87	0.37	0.37	0.00	1.87	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.29	9.72	5.49	0.42	0.00	0.63	6.13	0.84	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	8.51	1.74	1.74	0.39	0.19	0.39	2.32	0.97	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	39.68	7.71	12.30	3.12	2.30	1.31	2.95	1.48	1.64	0.00
gastric cancer cell line:GSS	10560-108A2	10.07	0.92	4.58	0.92	0.00	0.00	4.58	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.56	5.48	4.80	2.28	0.23	0.91	2.28	0.46	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	3.79	4.02	0.46	0.57	0.00	0.23	0.34	0.46	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	15.26	6.86	5.18	0.28	0.56	0.28	3.50	0.56	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.19	4.49	2.24	1.75	1.50	0.25	2.24	2.24	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.61	4.12	5.38	2.43	0.11	0.32	6.12	0.53	1.58	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	11.09	3.09	4.35	1.97	0.42	0.28	8.85	0.98	0.70	0.00
glioblastoma cell line:T98G	10485-107A8	20.75	5.96	10.93	2.32	0.55	0.33	9.38	1.77	2.54	0.00
glioma cell line:GI-1	10413-106B8	9.66	3.22	4.98	1.46	1.17	0.59	7.32	1.46	2.34	0.00
globus pallidus - adult, donor10196	10175-103C4	14.58	7.29	8.75	0.73	2.92	0.00	9.48	0.73	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	54.92	18.55	16.60	2.69	3.66	0.98	10.98	2.44	2.44	0.00
globus pallidus, adult, donor10258	10367-105F7	30.12	6.85	5.48	1.37	1.37	1.37	12.32	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	20.25	5.33	1.60	1.07	2.13	0.00	4.80	0.00	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	29.37	0.00	17.13	0.00	0.00	0.00	2.45	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.44	3.52	1.28	0.32	0.32	0.32	1.60	0.00	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	24.33	2.30	5.51	1.38	0.00	0.00	1.38	1.38	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	21.03	1.83	6.40	0.46	0.46	0.00	2.29	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	1.29	5.80	0.64	0.00	0.00	3.22	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	31.62	1.44	4.31	1.44	0.00	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	11.66	0.69	6.17	2.06	0.00	0.69	2.06	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	24.28	4.41	1.10	1.10	1.10	0.00	6.62	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	20.40	5.75	3.45	0.57	1.15	0.29	2.59	0.86	0.29	0.00
heart - mitral valve, adult	10205-103F7	9.87	3.59	5.98	1.79	0.30	0.30	6.28	0.60	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	21.44	4.71	8.63	1.05	1.83	0.26	10.72	2.09	1.31	0.00
heart - tricuspid valve, adult	10207-103F9	8.33	9.16	8.33	1.67	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	16.32	2.04	2.65	0.20	0.82	0.00	7.35	1.63	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	16.61	2.98	5.96	1.28	0.85	0.00	12.77	1.28	0.43	0.43
heart, adult, pool1	10016-101C7	4.60	2.30	2.53	0.00	0.00	0.00	8.51	0.69	0.00	0.00
heart, fetal, pool1	10046-101G1	26.80	4.83	13.66	2.77	1.33	0.41	12.94	2.67	0.92	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.17	5.55	2.47	0.62	0.31	0.00	4.63	1.23	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	5.95	3.57	1.19	0.00	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.83	4.64	11.71	9.39	0.66	0.11	2.32	0.99	0.66	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.52	5.95	13.72	9.35	0.97	0.61	3.03	1.21	1.34	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	34.36	6.16	15.56	11.22	0.61	1.31	4.14	0.91	1.62	0.10
hepatoma cell line:Li-7	10484-107A7	14.79	3.23	6.01	2.00	0.22	0.44	3.23	1.22	1.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.20	4.82	5.23	3.72	0.70	0.40	4.32	1.11	0.60	0.00
hippocampus - adult, donor10196	10169-103B7	16.09	3.79	8.52	0.00	0.00	0.00	10.41	1.89	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	55.92	15.72	21.84	4.08	2.45	1.02	17.55	4.29	2.45	0.00
hippocampus, adult, donor10258	10374-105G5	19.42	7.47	4.48	0.50	2.99	0.00	9.46	2.49	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	13.39	5.29	5.64	1.06	0.70	0.35	1.41	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.80	1.83	6.71	1.22	0.61	0.61	0.61	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.02	3.14	5.30	1.57	1.37	0.20	0.98	0.59	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	25.90	2.54	4.57	1.78	1.02	0.25	0.51	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	22.55	3.38	5.64	0.56	2.26	0.00	3.38	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.44	2.07	8.26	1.03	2.58	0.00	3.87	3.10	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.30	1.52	6.07	0.38	2.28	0.76	6.83	1.90	3.04	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.71	4.38	6.13	1.17	3.80	0.00	4.09	1.17	2.04	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	51.06	4.95	7.97	1.94	3.66	0.22	5.60	1.29	1.51	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.30	2.92	4.59	0.83	3.75	0.42	2.92	2.09	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	53.99	5.68	8.05	2.60	1.42	0.24	5.92	1.89	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.09	5.63	7.88	1.77	3.05	0.96	4.66	1.93	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.11	4.04	8.75	1.35	1.35	0.67	5.39	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.14	2.50	5.32	2.19	0.78	0.63	0.63	0.00	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.99	3.44	5.90	1.47	0.49	0.49	0.49	0.98	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	17.46	0.00	4.36	2.62	0.87	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.18	1.72	4.39	0.95	4.39	0.00	6.87	2.48	3.05	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.01	0.87	4.80	1.31	1.74	0.87	4.80	2.18	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	19.99	0.50	6.00	1.50	1.50	0.00	2.00	1.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	34.66	2.64	2.83	0.38	7.54	0.00	4.90	1.88	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.01	2.27	5.91	2.27	4.55	0.45	5.00	1.36	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.90	2.51	4.07	0.94	3.45	0.00	4.39	1.88	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	45.23	4.08	6.37	2.61	1.47	0.65	3.76	1.47	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	46.16	5.23	5.81	1.74	1.45	0.29	5.52	1.45	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.88	7.47	5.08	1.49	1.49	0.30	4.48	2.39	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.60	1.85	5.36	2.22	0.55	0.37	1.48	0.37	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	1.43	6.85	2.57	0.00	0.00	2.57	0.57	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	27.77	2.86	7.35	1.63	0.41	0.00	2.04	0.82	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	36.26	2.11	4.93	0.70	1.06	0.35	6.34	2.82	2.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	28.82	2.85	5.38	0.95	1.27	0.32	3.17	1.58	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.63	3.63	6.36	1.51	1.21	0.00	5.75	1.21	1.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.30	6.72	7.24	3.10	2.59	0.00	8.79	3.62	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.87	6.64	7.97	2.66	3.32	0.66	5.31	0.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.07	3.59	5.64	1.03	2.05	0.00	5.13	0.00	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.37	5.88	5.11	3.07	1.28	0.00	6.39	0.77	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	51.49	4.54	6.82	3.79	1.51	0.76	9.84	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.25	10.08	3.36	2.69	0.67	0.00	4.70	0.67	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	29.71	1.45	7.25	2.66	0.48	0.48	1.45	1.69	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.07	1.78	4.90	2.67	0.89	0.89	2.67	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	1.95	5.85	1.46	0.98	0.49	0.00	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.95	2.75	8.86	0.31	0.92	0.31	6.42	3.06	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	6.51	13.01	0.00	0.00	0.00	9.76	3.25	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	24.82	1.65	5.96	1.65	1.65	0.00	6.29	1.32	2.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.99	6.02	8.76	1.64	1.64	0.00	8.21	4.93	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.70	5.07	5.07	1.81	3.98	0.36	5.79	0.72	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.59	4.98	6.05	2.85	3.20	0.00	2.49	1.42	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	2.39	10.74	2.39	4.77	0.00	5.97	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	53.36	7.85	13.27	3.39	0.95	0.54	6.50	1.76	2.57	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.52	5.93	8.35	3.23	1.08	0.27	3.77	0.27	0.81	0.00
immature langerhans cells, donor1	11904-125F5	5.81	4.36	1.21	0.24	0.48	0.00	1.70	0.00	0.24	0.00
immature langerhans cells, donor2	11905-125F6	4.75	1.58	0.00	0.00	0.00	0.00	4.75	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	28.30	10.41	16.37	2.93	1.89	1.42	26.59	2.56	2.56	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	7.15	6.83	4.55	2.28	0.98	0.33	1.30	1.63	0.33	0.00
kidney, adult, pool1	10017-101C8	9.81	9.91	5.31	1.40	0.80	0.10	5.51	1.20	0.20	0.00
kidney, fetal, pool1	10045-101F9	31.69	12.66	15.35	2.05	1.13	1.13	7.99	2.05	0.71	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	6.25	1.14	1.42	0.00	0.14	0.00	2.27	0.57	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.95	5.25	4.56	0.00	0.28	0.41	1.80	0.83	1.11	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.82	3.30	0.55	0.18	0.73	0.00	7.89	4.04	2.57	0.00
left atrium, adult, donor1	10079-102A7	4.36	0.54	3.27	0.54	0.00	0.00	11.99	1.63	1.09	0.00
left ventricle, adult, donor1	10078-102A6	4.55	1.01	2.53	0.00	0.00	0.00	8.09	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	22.71	2.74	7.66	1.92	0.82	0.27	4.38	1.92	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	12.21	6.47	2.16	0.00	0.72	0.00	1.80	0.00	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	5.43	4.89	1.09	0.00	0.00	0.00	1.63	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	6.80	4.86	1.94	0.73	0.49	0.00	4.13	0.73	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	10.46	6.27	2.09	0.00	0.00	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.99	3.19	2.60	1.65	0.35	1.06	0.71	0.59	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	12.03	4.69	4.22	0.31	0.31	0.16	7.34	1.25	1.41	0.16
liposarcoma cell line:SW 872	10726-110A6	9.14	3.05	5.36	1.10	0.00	0.49	3.17	0.85	0.97	0.00
liver, adult, pool1	10018-101C9	5.02	7.78	5.67	1.46	0.00	0.65	4.86	1.46	0.65	0.00
liver, fetal, pool1	10086-102B5	16.93	1.88	0.94	0.00	0.00	0.00	5.64	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.27	5.83	5.40	2.48	4.08	0.58	9.62	1.31	2.92	0.00
locus coeruleus, adult, donor10252	10165-103B3	44.85	8.67	12.73	2.58	2.40	1.11	10.33	3.88	2.03	0.00
locus coeruleus, adult, donor10258	10375-105G6	41.19	8.75	8.75	1.97	1.13	0.56	12.98	4.51	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	24.82	9.67	12.20	4.63	0.84	0.00	3.79	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	4.29	4.29	2.08	0.00	0.55	0.55	0.69	0.28	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	28.27	12.41	6.89	1.38	2.07	0.69	8.96	0.00	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.92	5.54	3.16	0.66	1.45	0.13	5.93	3.03	0.79	0.00
lung, adult, pool1	10019-101D1	9.80	3.66	2.48	0.47	0.24	0.12	2.24	0.95	1.06	0.00
lung, fetal, donor1	10068-101I5	21.69	9.70	7.14	2.28	0.57	0.29	6.85	1.14	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	3.67	2.75	2.29	0.46	0.92	0.00	6.87	1.83	1.37	0.00
lymph node, adult, donor1	10077-102A5	5.68	6.15	3.31	0.00	0.00	0.00	1.89	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	10.74	3.07	1.75	0.44	0.22	0.22	0.66	0.88	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	17.21	7.09	17.21	6.49	0.60	0.91	2.41	0.75	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	6.80	3.40	0.00	0.00	0.00	0.85	0.00	2.55	0.00
mature adipocyte, donor1	12231-129F8	15.10	5.77	6.22	0.44	0.00	0.00	12.43	1.33	2.66	0.00
mature adipocyte, donor2	12232-129F9	12.04	2.91	3.53	1.04	1.25	0.00	9.55	1.66	2.28	0.00
mature adipocyte, donor3	12233-129G1	7.82	3.56	3.56	1.66	0.95	0.47	15.65	2.37	1.90	0.00
mature adipocyte, donor4	12234-129G2	12.37	3.69	4.21	1.58	1.58	0.00	7.11	1.05	1.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.02	12.39	11.20	3.10	0.71	0.71	9.53	2.14	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	6.77	14.66	0.00	2.26	0.00	12.41	4.51	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	39.72	13.98	17.84	3.49	3.13	0.92	9.20	1.84	0.92	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	14.93	3.18	7.62	0.95	1.59	0.32	7.31	4.13	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	8.96	10.66	5.97	1.28	0.85	0.43	3.41	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	25.14	8.94	10.80	2.03	2.03	0.84	14.18	2.19	1.01	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	42.02	14.86	14.43	2.12	1.49	0.64	8.06	1.70	1.70	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	7.71	1.93	0.00	1.93	0.00	5.78	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	14.35	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	7.54	3.95	2.15	0.72	0.36	2.51	1.08	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	41.53	7.79	14.28	3.24	1.30	0.00	11.68	2.60	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	56.04	15.17	16.41	3.25	2.48	2.17	17.34	5.26	3.25	0.00
medulla oblongata, adult, pool1	10038-101F2	49.06	13.39	13.80	6.20	3.67	1.31	29.55	3.59	7.35	0.00
medulla oblongata, newborn, donor10223	10361-105F1	37.15	9.03	9.03	3.47	3.82	0.00	6.60	1.04	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	44.73	7.09	11.51	4.21	0.66	0.66	7.31	2.66	1.99	0.00
medulloblastoma cell line:ONS-76	10759-110E3	23.72	4.16	4.89	2.20	0.24	0.24	3.67	1.47	1.59	0.00
melanoma cell line:COLO 679	10514-107E1	8.77	2.44	2.01	1.58	0.00	0.57	1.44	0.86	0.72	0.00
melanoma cell line:G-361	10465-106H6	11.94	15.47	10.86	1.90	0.27	0.54	4.61	1.90	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	3.98	1.81	1.27	0.18	0.00	0.18	3.26	0.72	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	74.02	21.15	37.89	12.34	0.88	0.00	12.34	2.64	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	58.84	12.96	18.66	3.37	0.52	0.26	4.41	2.33	1.81	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.37	2.15	3.53	1.84	0.00	0.46	5.83	1.07	1.07	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	2.36	2.54	1.27	0.36	0.73	5.09	0.36	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.87	3.73	2.07	0.41	0.00	0.00	1.66	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.64	2.11	2.95	0.98	0.28	0.14	3.09	0.42	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	2.70	1.54	1.93	0.77	0.19	0.19	3.47	0.58	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	2.78	2.78	0.69	0.00	0.69	2.78	0.69	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.12	3.78	3.60	0.51	0.00	0.17	3.09	0.69	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.37	2.53	1.38	0.69	0.00	0.23	1.50	0.58	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3.98	1.72	2.12	0.66	0.00	0.13	2.65	0.40	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.73	1.49	1.08	0.41	0.00	0.27	1.22	0.27	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.55	1.56	1.99	0.57	0.00	0.00	1.42	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1.98	3.95	1.65	0.66	0.00	0.33	2.63	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.99	2.35	1.38	0.28	0.28	0.14	1.66	0.83	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	7.68	1.75	2.44	0.00	0.35	0.00	2.44	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.74	2.04	2.25	0.41	0.00	0.41	2.04	1.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	4.31	3.59	2.88	0.00	0.36	1.08	5.75	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.45	2.17	1.03	0.21	0.10	0.10	1.34	0.62	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	3.19	4.79	0.23	0.23	0.23	0.00	1.60	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	2.52	1.26	0.84	0.42	0.00	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	3.89	2.09	1.49	0.15	0.45	0.30	1.94	0.30	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	4.81	1.49	2.19	0.44	0.35	0.53	1.66	0.35	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.42	1.84	3.31	0.00	0.37	0.37	2.21	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	3.72	5.44	1.72	0.57	0.57	0.00	3.43	0.29	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.00	2.53	4.63	2.53	1.26	0.42	6.32	0.42	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	4.11	1.83	1.37	0.46	0.00	0.00	5.02	0.46	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.35	2.30	1.28	0.77	0.26	0.26	3.07	0.51	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.54	1.83	3.66	0.00	0.26	0.26	2.09	0.79	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.16	1.54	1.85	1.23	0.92	0.31	1.85	1.23	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.30	1.41	2.82	0.24	0.24	0.47	2.35	0.47	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	3.05	2.37	2.37	0.00	0.34	0.00	2.71	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.72	0.79	1.96	0.39	0.00	0.00	5.50	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	3.71	4.17	4.17	0.46	0.00	0.00	1.85	0.46	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.79	2.88	2.88	1.15	0.00	0.29	4.33	0.58	1.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.14	2.68	2.68	0.67	0.00	0.45	3.57	0.45	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.45	2.16	2.88	0.72	0.00	0.48	4.33	0.72	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	2.20	2.93	0.73	0.00	0.00	2.20	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.69	1.34	1.68	0.67	0.00	0.00	3.36	0.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.91	1.23	3.68	0.41	0.41	0.00	2.05	0.82	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	8.59	2.15	1.29	0.00	0.00	0.00	2.15	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	2.73	0.00	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	2.92	2.27	1.62	1.30	0.32	0.00	3.25	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	1.45	1.45	0.00	0.00	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.86	3.73	4.80	0.00	0.00	0.00	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	0.82	3.27	0.00	0.00	0.00	2.45	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.89	1.55	0.78	0.39	0.00	0.00	0.78	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	0.00	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	0.00	6.95	0.00	0.99	0.00	3.97	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	3.56	1.19	1.78	0.00	0.00	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1.22	0.00	2.44	0.00	0.00	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	1.90	1.27	0.00	0.00	0.00	3.80	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	2.07	2.41	1.03	0.69	0.34	1.72	1.03	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	6.45	8.60	0.00	0.00	2.15	4.30	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	3.99	0.00	0.00	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	6.89	0.00	3.44	0.00	6.89	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	1.63	2.85	2.04	0.00	0.00	4.07	0.00	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.79	0.79	3.18	1.59	0.00	0.00	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	4.13	2.95	1.77	0.00	0.00	2.95	0.00	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	4.05	4.05	3.43	0.00	0.62	4.36	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	5.35	4.01	1.34	0.00	0.00	6.68	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	1.18	2.37	0.00	0.00	0.00	3.55	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	7.70	2.57	2.57	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	6.20	2.75	2.07	0.00	0.00	0.69	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.93	3.46	5.94	2.47	0.49	0.00	3.46	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	3.36	3.36	3.36	0.00	0.00	5.61	2.24	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.00	1.27	7.00	1.27	0.00	0.00	5.72	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.46	4.84	4.03	1.61	0.00	0.00	4.84	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	4.36	4.36	0.00	0.00	0.00	10.90	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	2.53	1.27	1.27	0.00	0.00	11.40	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1.21	4.25	2.43	3.03	0.00	0.00	9.71	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	13.56	0.00	0.00	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	3.29	2.47	0.00	0.00	0.00	4.12	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.75	4.17	2.78	2.18	0.40	0.40	3.57	0.60	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	2.92	3.24	0.65	0.32	0.00	3.24	1.62	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	4.07	5.09	2.04	0.00	0.00	1.02	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	1.55	1.55	0.77	0.00	0.00	1.55	0.00	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	13.47	4.25	2.13	0.24	0.47	0.47	4.02	1.65	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	18.07	4.40	4.87	1.62	0.00	1.62	7.41	2.09	1.16	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	4.27	8.55	0.00	0.00	0.00	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.14	5.75	4.42	4.62	0.21	0.82	4.01	0.41	1.75	0.00
mesothelioma cell line:Mero-25	10850-111F4	12.03	4.54	3.18	0.91	0.68	0.00	1.59	0.68	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	13.20	11.00	6.11	2.20	0.49	0.24	2.69	0.49	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	10.63	9.30	6.86	1.11	0.44	0.66	7.09	0.89	0.89	0.00
mesothelioma cell line:Mero-82	10853-111F7	9.20	4.20	2.10	2.37	0.26	0.00	1.31	0.79	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	14.30	7.32	5.28	2.21	0.17	1.02	6.13	1.02	1.70	0.00
mesothelioma cell line:Mero-84	10855-111F9	8.34	3.03	2.02	2.27	0.25	0.25	4.80	0.76	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.00	2.69	2.48	0.83	0.21	0.21	3.11	0.62	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	9.11	6.46	3.48	1.99	0.17	0.50	2.48	0.17	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	5.43	4.52	2.53	0.72	0.00	0.36	3.26	0.54	1.27	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	9.74	5.30	5.30	0.51	0.17	0.51	4.78	1.02	2.73	0.00
mesothelioma cell line:NCI-H28	10845-111E8	20.61	10.18	4.33	1.02	0.00	0.76	2.54	0.00	1.02	0.00
mesothelioma cell line:No36	10857-111G2	15.66	4.24	2.61	1.63	0.33	0.00	0.98	0.98	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	7.32	5.15	2.17	1.08	0.00	0.54	6.50	0.54	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	84.06	24.57	9.98	3.07	2.88	0.38	11.52	0.96	1.15	0.00
migratory langerhans cells, donor2	11902-125F3	47.50	17.46	4.76	1.59	1.83	0.61	7.45	0.98	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	52.05	14.00	3.95	2.33	0.36	0.18	10.41	0.90	1.62	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.55	3.26	0.65	0.65	0.65	0.33	4.90	1.31	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.99	0.64	1.06	0.85	0.00	0.00	4.66	1.06	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.44	2.53	1.38	0.23	0.23	0.00	0.92	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.61	4.19	4.19	1.90	0.38	0.19	5.71	1.14	1.71	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.75	5.17	6.28	2.03	0.18	0.18	2.03	0.37	0.55	0.00
myeloma cell line:PCM6	10474-106I6	1.19	8.90	0.99	0.59	0.20	0.00	3.36	1.19	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	6.09	0.00	0.51	0.00	0.00	0.00	1.01	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.51	0.98	3.14	1.18	0.00	0.00	3.92	0.78	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.47	6.35	0.45	0.11	0.33	0.00	0.45	1.11	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.57	6.69	0.22	0.07	0.15	0.22	0.81	0.29	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	11.04	5.52	1.66	0.00	1.66	0.00	3.31	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	137.81	10.35	68.10	12.19	2.99	4.37	8.05	7.82	3.22	0.00
neuroblastoma cell line:NB-1	10539-107G8	47.71	3.93	8.79	1.68	2.99	0.37	8.98	2.06	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	28.26	1.90	4.85	4.22	1.27	0.42	5.69	1.90	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	67.27	5.22	17.52	2.80	5.40	0.93	6.71	4.47	8.01	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	30.60	3.32	9.96	3.80	1.19	0.95	6.64	1.42	1.42	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.57	2.38	6.97	1.43	1.11	1.11	3.33	0.95	0.79	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	28.18	1.81	6.04	2.01	1.61	0.81	4.03	1.21	2.82	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.71	2.54	2.54	0.64	0.64	0.00	1.27	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	6.92	1.86	3.46	1.33	0.27	0.27	3.73	0.53	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	19.11	2.54	6.60	1.01	0.68	0.17	5.58	1.86	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	8.81	3.20	0.00	2.40	0.00	7.20	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	12.18	2.56	3.85	2.56	1.28	0.32	4.17	2.89	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.14	3.68	2.10	1.58	0.53	0.00	3.15	0.53	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	32.90	12.09	15.84	2.91	1.50	1.50	27.75	2.72	2.53	0.00
occipital cortex - adult, donor10196	10172-103C1	14.42	2.06	10.30	4.12	0.00	0.00	6.18	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	44.01	11.81	14.76	2.15	1.61	0.54	10.20	2.95	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	16.74	8.37	6.55	1.46	0.36	0.00	3.28	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	17.58	3.94	8.13	1.84	1.05	0.00	15.48	1.84	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	65.22	8.15	14.16	4.29	4.72	0.43	5.15	0.86	1.29	0.00
occipital pole, adult, pool1	10036-101E9	24.84	7.65	14.11	3.00	1.73	1.18	17.42	1.89	2.05	0.00
olfactory region, adult	10195-103E6	27.70	7.64	8.60	2.29	1.72	0.38	17.77	2.48	2.48	0.00
optic nerve, donor1	10277-104E7	16.01	16.01	0.00	0.00	2.00	2.00	2.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	34.51	13.21	10.48	6.38	1.25	0.46	5.13	1.71	2.28	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.64	1.37	3.98	0.96	0.69	0.27	2.89	1.79	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.98	2.71	1.86	1.19	1.02	0.00	1.02	0.17	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.16	2.43	1.16	0.23	0.46	0.12	2.08	0.81	0.92	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	7.64	3.23	2.06	0.29	0.00	1.18	2.65	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	8.41	0.93	2.80	0.00	0.00	0.00	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	17.60	2.12	12.94	5.73	0.42	0.64	5.94	1.70	2.12	0.00
ovary, adult, pool1	10020-101D2	28.56	5.07	10.74	3.58	1.40	0.52	7.60	1.92	1.92	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.28	2.20	1.47	0.92	0.92	0.37	2.75	1.28	0.37	0.18
pancreas, adult, donor1	10049-101G4	10.35	8.47	4.70	0.00	1.88	0.00	5.64	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	25.72	9.50	6.43	0.28	1.12	0.00	2.24	0.84	1.12	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	9.03	5.62	3.92	1.19	0.00	0.51	6.13	0.68	1.19	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	7.62	8.94	4.64	0.66	0.17	0.17	3.31	0.33	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	26.72	10.43	10.98	2.93	2.01	0.64	16.75	2.29	2.75	0.00
parietal cortex, adult, donor10258	10373-105G4	22.75	2.94	8.07	0.73	0.73	0.73	4.40	0.00	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	16.93	1.88	9.40	0.94	0.94	0.00	9.40	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	23.37	8.55	13.11	3.71	1.14	0.86	6.84	2.28	2.57	0.00
parietal lobe, adult, pool1	10034-101E7	28.64	9.43	13.22	2.64	1.94	1.23	18.86	3.70	2.11	0.00
parietal lobe, fetal, donor1	10072-101I9	42.67	6.79	11.64	2.91	3.88	1.94	2.91	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	15.33	8.97	4.11	0.75	0.75	0.37	1.87	0.37	0.00	0.00
parotid gland, adult	10199-103F1	33.30	7.40	4.93	0.00	2.47	0.00	8.02	2.47	1.23	0.00
penis, adult	10200-103F2	12.35	6.45	4.83	0.54	0.54	0.00	4.83	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.08	8.92	5.95	1.67	0.74	1.49	3.53	0.56	1.86	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.91	3.06	3.50	0.87	0.29	0.15	3.64	1.02	0.44	0.00
pineal gland - adult, donor10196	10179-103C8	19.35	7.10	7.74	1.94	0.65	0.00	3.87	3.23	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	40.27	14.81	20.14	4.74	2.37	0.59	9.48	5.33	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	25.08	5.64	7.52	1.25	0.63	1.25	5.64	1.25	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	37.44	11.13	12.14	0.00	1.01	0.00	16.19	4.05	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	64.63	24.50	23.45	1.04	2.08	1.56	19.28	13.03	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	30.64	7.66	7.66	1.70	1.70	0.00	17.88	0.85	2.55	0.85
placenta, adult, pool1	10021-101D3	13.01	8.17	2.37	0.32	0.65	0.11	2.90	0.86	0.32	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	9.14	4.37	5.16	0.93	0.26	0.53	4.24	0.79	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	4.36	2.33	2.18	0.62	0.31	0.31	8.72	1.56	0.93	0.00
pons, adult, pool1	10033-101E6	23.93	7.32	9.47	2.15	1.55	0.77	17.04	2.15	3.10	0.09
postcentral gyrus, adult, pool1	10032-101E5	22.49	8.63	10.90	2.35	2.01	0.96	17.61	3.92	1.57	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	4.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.63	6.99	6.55	1.46	0.15	0.73	4.95	0.73	0.73	0.00
prostate cancer cell line:PC-3	10439-106E7	21.42	8.89	10.35	3.27	0.73	0.36	4.90	0.73	0.73	0.00
prostate, adult, pool1	10022-101D4	27.03	5.53	6.35	1.72	2.18	0.91	5.62	1.00	1.27	0.09
putamen, adult, donor10196	10176-103C5	27.86	15.34	16.52	3.07	2.36	0.47	18.18	4.25	1.65	0.00
putamen, adult, donor10252	10152-102I8	19.61	9.80	5.88	1.96	0.00	0.00	3.92	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	4.37	5.46	0.00	0.00	0.00	5.46	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	21.99	9.18	7.73	1.45	1.21	1.45	11.84	3.38	0.72	0.00
putamen, newborn, donor10223	10365-105F5	8.25	10.50	9.00	3.00	0.00	0.00	2.25	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	7.27	6.40	1.75	0.58	0.29	0.87	0.00	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	20.86	0.00	9.74	4.17	0.00	0.00	0.00	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.66	10.60	4.88	1.48	0.21	0.21	10.18	2.12	2.33	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.40	6.63	3.31	0.83	1.24	1.66	29.41	4.56	1.24	0.00
retina, adult, pool1	10030-101E3	36.98	10.74	14.31	3.58	1.19	0.80	18.49	3.78	1.29	0.00
retinoblastoma cell line:Y79	10475-106I7	24.94	1.30	10.13	2.60	0.78	0.52	2.86	1.30	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.65	5.16	6.89	2.95	2.34	0.86	8.36	1.23	1.23	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	64.96	1.97	6.19	0.28	2.25	0.28	3.37	0.84	1.12	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.06	1.52	3.79	0.00	0.76	0.00	1.52	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	10.84	10.20	4.21	1.46	0.49	0.65	2.59	0.97	1.13	0.00
salivary acinar cells, donor2	11772-123I8	9.78	13.49	7.85	2.34	0.14	0.28	4.41	0.55	0.69	0.00
salivary acinar cells, donor3	11773-123I9	5.96	7.28	6.62	0.66	0.00	0.00	1.32	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	38.89	17.73	4.00	2.29	0.57	0.57	4.58	3.43	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.24	4.13	5.06	0.93	0.25	0.59	5.99	0.76	1.10	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	3.41	1.65	4.47	0.71	0.00	0.12	4.00	0.59	0.82	0.00
seminal vesicle, adult	10201-103F3	17.46	13.23	8.47	0.53	1.59	0.53	10.58	0.00	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	1.21	1.21	0.49	0.73	0.00	5.59	0.97	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.30	2.01	1.76	0.75	0.00	0.00	2.77	0.00	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	1.00	3.01	0.00	0.00	0.00	3.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	13.97	7.79	2.69	0.27	1.07	0.27	1.21	0.67	1.48	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	13.26	6.85	2.76	0.33	0.33	0.55	3.32	1.33	0.55	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.23	6.84	4.52	1.29	0.52	1.03	2.32	0.52	1.16	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	1.42	4.26	0.00	0.00	0.00	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	11.87	1.68	2.40	1.08	0.84	0.00	3.84	0.96	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	12.06	2.01	8.04	0.00	1.01	0.00	2.01	2.01	4.02	0.00
skin, adult, donor1	10074-102A2	13.57	6.79	0.00	6.79	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	23.99	4.42	3.79	1.26	0.63	0.63	15.78	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.35	3.34	6.67	2.00	1.00	0.33	8.34	3.00	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.29	7.88	17.02	5.67	0.00	1.58	7.56	0.95	1.89	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.99	7.90	4.63	0.39	0.58	0.19	5.40	1.35	1.35	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	36.10	14.67	10.88	2.31	0.66	1.32	4.62	2.14	0.66	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.25	2.09	3.06	0.48	2.73	0.16	3.06	1.61	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.74	6.10	3.05	1.09	1.31	0.44	12.20	1.53	1.31	0.00
small intestine, adult, pool1	10024-101D6	6.57	6.45	3.46	0.36	0.12	0.24	3.46	0.96	0.36	0.00
small intestine, fetal, donor1	10064-101I1	16.95	5.65	4.18	1.23	0.49	0.25	2.46	1.23	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.46	15.39	6.67	0.51	0.51	0.00	10.26	2.56	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	15.77	3.88	6.72	0.26	1.03	0.52	10.34	1.81	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	9.65	18.76	2.41	0.80	0.00	0.27	0.54	1.07	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	33.03	8.26	7.80	2.75	3.21	0.69	14.68	2.29	5.05	0.00
spinal cord, adult, donor10252	10159-103A6	42.19	11.43	11.83	1.58	2.37	0.39	17.35	4.73	5.52	0.00
spinal cord, adult, donor10258	10369-105F9	39.43	11.76	13.14	5.53	3.46	0.69	11.07	2.08	6.23	0.00
spinal cord, fetal, donor1	10056-101H2	23.17	7.93	4.27	1.22	0.61	1.83	9.15	2.44	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	11.48	13.32	8.73	4.59	0.46	0.92	4.59	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	8.96	2.39	1.49	0.60	0.45	0.15	0.90	1.19	0.15	0.00
spleen, adult, pool1	10025-101D7	5.73	3.63	4.41	0.22	0.11	0.22	1.32	0.33	0.00	0.00
spleen, fetal, pool1	10044-101F8	15.41	8.82	9.53	1.19	0.40	0.40	2.94	0.79	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.56	5.07	2.38	0.62	1.04	0.10	3.62	0.72	0.62	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.04	2.85	1.71	0.38	0.38	0.19	0.57	0.19	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.96	3.49	4.19	0.70	0.70	0.35	2.45	1.40	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	1.95	0.00	0.00	0.39	0.00	1.17	1.17	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	12.38	11.37	1.91	0.56	1.13	0.23	6.42	3.15	1.46	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.18	4.66	2.54	1.69	2.54	0.00	3.39	0.00	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.08	1.69	5.92	2.12	0.00	0.00	1.27	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	11.75	4.27	1.07	0.00	1.07	1.07	3.20	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	37.60	3.42	5.70	0.57	1.14	0.00	0.57	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	39.67	17.66	12.46	1.45	2.28	1.45	13.09	2.70	4.15	0.00
substantia nigra, adult, donor10258	10371-105G2	34.66	5.69	5.17	1.55	1.55	1.55	10.35	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.73	10.60	5.65	0.00	0.00	0.00	3.53	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	26.37	2.29	12.15	3.67	1.15	1.15	2.06	0.69	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	28.48	9.66	11.87	3.31	1.53	1.19	22.97	3.73	2.54	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	71.23	12.82	23.50	4.99	2.85	0.00	5.70	0.71	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	64.17	8.35	15.38	0.00	3.96	0.44	6.59	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	12.92	3.84	5.24	1.40	0.35	0.35	5.24	0.00	1.05	0.00
tenocyte, donor2	11765-123I1	8.01	6.87	3.43	1.91	0.00	0.00	10.68	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	8.53	5.93	4.82	1.11	0.74	0.00	7.04	0.74	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	34.16	4.25	11.90	6.63	1.19	1.36	3.57	0.68	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	39.00	2.62	6.47	1.85	1.39	0.31	2.93	1.85	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	44.48	3.10	8.99	1.86	1.24	0.15	3.72	2.17	1.55	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.55	3.05	2.54	1.40	0.76	0.25	0.89	0.51	1.02	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.82	1.13	5.29	1.13	0.00	0.00	1.89	0.38	3.03	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.05	0.44	0.44	0.22	0.22	0.00	0.44	0.87	1.20	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.89	0.65	1.95	1.30	0.65	0.00	2.93	1.30	0.98	0.00
testis, adult, pool1	10026-101D8	14.92	6.66	5.37	1.50	1.07	0.11	7.41	1.83	1.50	1.18
testis, adult, pool2	10096-102C6	17.59	9.92	4.96	3.16	1.35	0.45	9.47	1.35	0.45	9.92
thalamus - adult, donor10196	10168-103B6	28.70	8.83	17.66	2.21	1.10	1.10	15.46	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	41.26	16.41	12.66	2.50	2.50	1.25	12.19	3.44	2.19	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	9.24	9.24	0.00	0.00	0.00	3.08	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.72	4.78	4.94	1.81	1.32	0.33	7.74	3.13	0.99	0.00
thalamus, newborn, donor10223	10366-105F6	9.21	5.18	3.45	2.30	0.00	1.15	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	14.98	6.24	5.49	0.50	1.00	0.00	4.99	0.75	1.00	0.00
throat, fetal, donor1	10061-101H7	19.50	7.01	6.70	1.83	1.83	0.30	8.23	1.52	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	31.40	14.90	28.62	11.92	1.39	1.39	11.33	1.99	6.36	0.00
thymus, adult, pool1	10027-101D9	34.50	16.20	8.75	1.79	1.39	0.70	4.67	1.29	1.19	0.00
thymus, fetal, pool1	10043-101F7	30.44	18.18	10.49	1.35	1.45	0.62	7.59	0.94	0.62	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.78	2.66	1.33	1.33	0.27	0.00	3.06	0.53	1.06	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	8.66	2.37	4.19	1.40	0.14	0.56	5.03	1.12	0.84	0.00
thyroid, adult, pool1	10028-101E1	20.16	21.18	9.80	1.68	0.56	0.56	9.52	1.77	0.56	0.00
thyroid, fetal, donor1	10060-101H6	34.80	13.18	7.12	1.32	1.05	1.05	3.43	1.05	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	6.16	0.00	0.00	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	10.93	5.12	3.49	0.23	0.70	0.00	2.56	0.70	0.23	0.00
tongue, fetal, donor1	10059-101H5	11.03	3.55	5.91	1.18	0.00	0.00	4.73	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	23.34	14.73	8.01	1.80	0.40	0.40	4.71	0.90	0.70	0.00
trachea, adult, pool1	10029-101E2	16.44	7.69	5.15	1.31	0.82	0.41	3.84	0.65	1.31	0.00
trachea, fetal, donor1	10058-101H4	25.39	3.85	6.92	1.54	1.92	0.00	4.23	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.38	3.19	1.42	0.71	0.00	0.00	1.42	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	37.18	3.44	5.27	1.93	1.01	0.20	2.43	1.52	0.71	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	8.15	7.36	6.74	2.82	0.31	0.78	7.68	1.25	3.45	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	9.40	2.88	2.29	0.34	0.17	0.51	1.69	0.76	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	10.43	0.00	2.09	4.17	2.09	0.00	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	26.79	7.17	10.07	1.19	0.34	0.68	5.29	1.19	0.51	0.00
uterus, fetal, donor1	10055-101H1	25.60	3.58	11.26	2.05	2.05	1.54	2.56	1.02	0.00	0.00
vagina, adult	10204-103F6	11.63	3.23	6.46	1.29	0.65	0.65	5.82	0.65	0.00	0.00
vein, adult	10191-103E2	9.43	8.99	4.38	0.44	0.22	0.00	6.14	0.44	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.89	2.14	2.67	0.53	0.27	0.27	3.47	0.80	0.53	0.00